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Abstract 
 
     Transmissible spongiform encephalopathies (TSEs) are fatal, neurodegenerative diseases 
in human and animals, caused by misfolding and aggregation of the host-encoded prion 
protein (PrP). The functions of PrP and the basis of these diseases are still under debate. In the 
present study characteristics of a possible PrP binding parter (prion protein interactor PINT), 
have been studied. 
 
     Four ovine PINT constructs were used for expression of protein in prokaryotic (E.coli) and 
eukaryotic cell lines (murine neuroblastoma cells (N2a) and human neuroblastoma cells (SH-
SY5Y)). Overexpression of PINT-His6 protein in E.coli led to the formation of insoluble 
inclusion bodies, which did not depend on growth temperature (16- 37ºC was used). Transient 
and stable transfections in mammalian cells, and fluorescence protease protection (FPP) assay 
allowed a detailed study of the cellular localization of PINT protein. PINT was shown to be 
localized both in cytosol and in the cell nucleus; some of the cytosolic PINT-DsRed-Ex 
appeared also to be bound to membranes. It was shown that PINT-DsRed-Ex is resistant to 
trypsin digestion, but not to proteinase K. Application of unboiled lysates on the gel showed 
that PINT-DsRed-Ex tends to form oligomers in transiently transfected cells. To study the 
possible interaction between PINT and PrP, immunoprecipitation assay was performed. 
Lysates of transfected N2a-PrP-EGFP cells were added anti-RFP (directed against PINT-
DsRed-Ex) or P4 (directed against PrP) antibodies and antibody binding proteins such as 
Protein A or Protein G. Signals were detected with antibodies directed against both proteins. 
Immunoprecipitation assay confirmed weak interaction between PrP and PINT protein.  
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Abbreviations 
 
ALP              alkaline phosphatase  
Amp              ampicilin 
ATP               adenosine triphosphate 
BHK cells     baculovirus- transducted baby hamster kidney cells 
bp                 base pair 
BSA              bovine serum albumin 
CBB              Coomasie Brilliant Blue 
CBP              carbohydrate binding protein 
Chl                chloramphenicol 
Co-IP           co-immunoprecipitation 
DMEM         Dulbecco's modified Eagle's medium 
DMSO          dimethyl sulphoxide 
dNTP            deoxyribonucleotide 
ECL              enhanced chemiliuminescence 
EDTA           ethylenediaminetetraacetic acid 
EGFP            enhanced green fluorescent protein 
ER                endoplasmic reticulum 
FBS              foetal bovine serum 
FPP               fluorescence protease protection 
GB1              protein G domain 
GFAP           glial fibrillary acidic protein 
GPI               glycosyl-phosphatidylinositol 
GST             glutathione-S-transferase  
HRP             horse radish peroxidase 
HSP             heat shock protein 
ICH              immunohistochemistry 
IDA              iminodiacetate 
IP                 immunoprecipitation 
IPTG            isopropyl β-D-1-thiogalactopyranoside 
kDa              kilo daltons 
LB                Lysogeny broth medium  
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MBP            maltose binding protein 
MEM           minimum essential medium 
mRNA         messenger RNA  
MW             molecular weight 
N-CAM      cell adhesion molecule 
NLS            nuclear localization signal 
NTA            nitrilotriacetic acid 
NusA           E.coli protein 
ORF            open reading frame 
PBS             phosphate buffered saline 
PBS-T         PBS-tween 
PCR             polymerase chain reaction 
PINT            prion interactor 
PNGase F    peptide N- glycosidase F 
PrPC             the cellular form of prion protein 
PrPSC           disease related form of prion protein 
psi                pound-force per square inch  
RFP             red fluorescence protein 
RT               room temperature 
SDS             sodium dodecyl sulphate 
Tg                transgenic 
TBS             tris buffered saline 
TBS-T         TBS-tween 
TRX            thioredoxin 
TSEs           transmissible spongiform encephalopathies 
ZZ               IgG binding protein 
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I. Introduction 
 
     Transmissible spongiform encephalopathies (TSEs), also known as prion diseases, are 
fatal, neurodegenerative diseases in human and animals caused by prions. TSEs include 
scrapie, bovine spongiform encephalophaty, kuru, Creutzfeldt-Jacob disease and some other 
disorders (Table 1). Prion diseases can be classified in to genetic, infectious, or sporadic, all 
of which involve modification of the cellular prion protein (PrPC).Genetic forms were traced 
to several mutations in PrPC, while, infectious forms were traced to previous infections. In 
contrast, most cases of prion diseases, known as sporadic forms, can neither be attributed to a 
previous infection nor mutation in a gene, and are supposed to occur by stochastic conversion 
of PrPC into abnormal form (reviewed by Prusiner, 1998). The normal function of PrP is still 
under discussion; the pathogenesis of prion disease requires its expression (Prusiner et al., 
1993) and is often accompanied by accumulation in the brain of an abnormal isoform (PrPSC).     
 
1. Cellular prion protein (PrPC) 
 
1.1 Structure of prion protein and some characteristics 
 
     PrPC is a soluble, glycosyl-phosphatidylinositol (GPI) anchored protein of 256 amino acids 
(sheep protein) with a molecular mass of 33-40 kDa, or 27 kDa in its unglycosylated form. 
This protein is highly conserved. Structurally, the protein has 5 glycine/proline rich 
octapeptide repeat regions, two strongly hydrophobic segments that can span the phospholipid 
layer, two N-linked glycosylation sites, a single disulphide bond, and signalling peptides at 
both termini (Bazan et al., 1987; Stahl et al., 1987).  
     PrP exists in two conformational isoforms: cellular- normal (PrPC) and disease associated- 
scrapie (PrPSC) isoform. The isoforms differ just three-dimmensional folding with different 
content of secondary structures conformation. PrPC is contains about 40% α-helical structures 
and less than 10% β-sheet. Yet, the content of β-sheet structures increases up to 60% with 
con-comitant decrease in α-helical structures in the misfolded disease-associated form of the 
protein. (Martins, 1999) (Figure 1). Cellular prion protein is easily degraded by proteinase K, 
while abnormal form is partly resistant to proteinase K treatment and physiol-chemical 
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manipulations such as, high temperature, formaldehyde treatment, UV and X-ray irradiation 
(reviewed by Harris, 2003; Prusiner, 1998).  
     PrPC internalization is mediated either by clathrin-coated pits or by caveolae-like 
membranous domains. However, both pathways seem to require an additional factor X to 
convert PrPC into PrPSC (Campana et al., 2005).  
 
 
Table 1: The prion disease (Prusiner, 1998) 
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     Resistance of the one species to infection with prion particles from another was also 
observed (Kocisko et al., 1995). Mice are normally resistant to hamster or human prions, and 
they become ill only when hamster/human transgene is introduced (hamster/human PrP gene 
is microinfected into fertilized murine embryos) (Scott, 1989; Telling et al., 1995); these 
findings argue that a species-specific molecule participates in prion formation.    
 
 
 
 
Figure 1: Two isoforms of secretory prion protein (α-he ix in red, β-sheet in blue).   l
(Taken from http://molvirology.huji.ac.il/research5.htm) 
 
1.2 Functions of cellular prion protein 
 
     The suggested physiological functions of prion protein are contrasting and include: 
function as a membrane receptor, regulation of apoptosis (Chiarini et al., 2002), carrier or 
binding protein for copper and/or zinc ions, effector in signal transduction mechanisms, 
protection from oxidative stress, neuritogenesis, regulator of synaptic transmission and 
transcription factor (reviewed by Campana et al., 2005; Griffoni et al., 2003). All these 
functions are supposedly achieved through the interaction with other proteins at various 
localizations in the cell (Table 2).    
 
1.3 Biosynthesis, different isoforms and cellular localization of PrP 
  
      Like other membrane proteins, PrPC is synthesized in the rough endoplasmic reticulum 
(ER) and travels through the Golgi apparatus to the plasma membrane. During its biosynthesis 
cellular prion protein undergoes a number of posttranslational modifications, such as cleavage 
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of the amino N-terminal signal peptide, addition of N-linked oligosaccharide chains, 
formation of a disulphide bonds and attachment of GPI anchor (Harris, 2003), which attach 
PrP to the outher leaflet of the plasma membrane. At the ER membrane, the prion protein can 
be synthesized in several topological forms: one that is fully translocated (secPrP) (located on 
plasma membrane) and two transmembrane forms; CtmPrP and NtmPrP, with the C-terminus 
facing ER lumen or cytosol, respectively (reviewed by Griffoni et al., 2003; Hegde et al., 
1998). Mironov and co-worke (Mironov et al., 2003) demonstrated that in neurons PrPC can 
be localized on all biosynthetic and endocytic transport membranous structures, and is 
expressed with the same frequency on presynaptic and postsynaptic membranes and in 
synapse, but almost no was found in synaptic vesicles. In a subset of neurons in the 
hippocampus and thalamus PrP is located predominantly in cytoplasm (Mironov et al., 2003).       
          The presice cellular location for the transformation of PrPC to PrPSC is still unknown. 
Campana and co-workers (Campana et al., 2005) concluded, that both, the plasma membrane 
and ER, are important, but they might be differently involved in prion formation. It is most 
likely, that the first contact between the physiological and pathological forms of PrP occurs at 
the plasma membrane, and the subsequent contact could occur either directly on the plasma 
membrane or after internalization. Campana and colleagues also reviewed the possible 
involvement of caveolae and clathrin-coated pits in internalization of PrPC.  
 
1.4 Factor X 
 
     At the beginning factor X was suggested to explain the conversion of PrPC to PrPSC (it was 
unknown what kind of molecule it might be), because this conversion was difficult to achieve 
in vitro (Prusiner, 1998); indeed, just recently it has been possible to generate the infectious 
agent in vitro (Legname et al., 2004). 
      Studies performed with transgenic (Tg) mice provided evidence about existence of protein 
X, which is involved in the conversion of the normal cellular prion protein into the scrapie 
isoform and which can function as a molecular chaperone in the formation of PrPSC (Telling 
et al., 1995). Transgenic mice expressing human prion proteins genes were inoculated with 
brain extracts from humans with prion disease. Although the mice expressed high levels of 
human PrPC, they were resistant to human prions, and only upon ablation of mouse PrP gene 
they became susceptible to human prions. Scott and colleagues (Scott et al., 1989) worked 
with a Tg mouse expressing hamster PrP; their findings indicate that the PrP gene modulates 
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scrapie susceptibility and incubation times. A species barrier between hamster and mice is 
maintained by differences in the primary structure of the PrP molecules of the donor and 
recipient host (14 amino acid substitutions out of 254) (Scott et al., 1989). By introduction of 
various substitutions in PrP protein it was demonstrated that binding of PrPC to protein X is 
likely to occur through specific side chains of amino acids located on the C-terminal of PrPC 
(Kaneko et al., 1997; Yehiely et al., 1997). Yehiely and colleagues postulated that PrPC first 
binds to protein X, and then PrPSC binds to PrPC resulting in a ternary complex (if PrPC and 
PrPSC are monomers or dimers are unknown). 
     Propositions that factor X is a protein, was required to explain the prion species barrier, but 
lately it was also suggested that factor X might be a RNA (Gabus et al., 2001; Weiss et al., 
1997) or DNA (Cordeiro et al., 2001; Nandi et al., 1999) molecule. Cordeiro and colleagues 
demonstrated that some nucleic acid sequences bind with high affinity to the murine PrP 
converting it to the β-sheet isoform, and that binding is sequence specific. They claimed that 
DNA stabilizes a soluble β-sheet structure, and that a macromolecular complex of prion-DNA 
may act as an intermediate for the formation of the growing fibber. At the same time, Gabus 
and coworkers showed that the prion protein has RNA binding properties (Gabus et al., 2001).  
     The nucleic acid can be the entire part of factor X or only a part of it. Supattapone and 
colleagues (Supattapone et al., 1999) demonstrated that polyamines (known to interact with 
nucleic acids) eliminate PrPSC from scrapie infected neuroblastoma cells.     
 
 1.5 Protein-protein interactions (in general) 
 
     Protein-protein interactions refer to the association of protein molecules and the study of 
these associations from the perspective of biochemistry and networks. Interactions between 
proteins are important for many biological functions. Specific interactions are operative in 
almost every level of cell function, in the structure of subcellular organelles, the transport 
machinery across the various biological membranes, packaging of chromatin, the network of 
sub-membrane filaments, muscle contractions, signal transduction from the exterior of a cell 
to the inside , and regulation of gene expression, to name a few.     
     Protein-protein interactions can be classified according to the function of the interaction, or 
by the time-scale of the interaction, which are related. Proteins might interact for a long time 
to form part of a protein complex, a protein may be carrying another protein (for example, 
from cytoplasm to nucleus or vice versa in the case of the nuclear pore importins), or a protein 
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may interact briefly with another protein just to modify it (for example, a protein kinase will 
add a phosphate to a target protein). 
      Four different types of protein complexes are possible (reviewed by Jones et al., 1996): 
homodimeric (they are usually permanent and optimized) and heterodimeric protein 
complexes (these complexes can have the same properties as homodimeric, but can also be 
nonobligatory, being made and broken according to the environment or external factors and 
involve proteins that must also exist independently), enzyme-inhibitor complex, and antibody-
protein interactions. Several fundamental properties that characterize a protein-protein 
interface are: size and shape of interfaces; electrostatic complementary between surfaces; 
residue interface propensities; hydrophobicity including hydrogen bonds (interaction through 
hydrophobic patches on protein surfaces most common, but polar interactions are possible 
too); segmentation and secondary structure; and conformational changes on complex 
formation (Jones et al., 1996). 
 
1.6 Interaction of PrPc with other proteins 
 
     Cellular prion protein is a quite well characterized protein, but its functions still remains 
enigmatic. Search for molecules that are able to interact specifically with the prion protein is a 
powerful tool in the hope to identify interactors that play an important role in the life of 
prions, or that could be developed into potent prion diseases therapeutics. Binding partners 
can help to elucidate functions of PrP, different subcellular localizations and the basis of 
diseases caused by the prion protein.       
     As mentioned before, prion protein can exist in different topological forms: secretory form, 
which is located on plasma membrane attached by a GPI anchor; 2 transmembrane forms with 
C- or N-terminal facing the cytosol. Some PrP is also found in the cytosol. There are a 
number of structural features within PrP that might allow it to interact with other proteins. 
Near the middle of the molecule, there is an amphiphatic helix (Bazan et al., 1987); in other 
proteins such helices take part in protein-protein interactions (Kaiser et al., 1984). The GPI 
anchor can also take part in interactions.  
     The prion protein has been reported to bind to or interacts with a large number of diverse 
proteins (Table 2), both intra- and extra cellular. 
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     The first interacting proteins identified were a pair of PrP ligands: pli 45 (later identified as 
GFAP (glial fibrillary acidic protein) and pli 110 from hamster brain extract (Oesch et al., 
1990). 
     Later, a number of other putative PrPC binding proteins have been identified using the 
yeast two- hybrid system (PrP was used as bait to search mouse or hamster brain cDNA; both 
bait and pray were derived from the same host in order to insure putative interactions); these 
include the anti-apoptotic protein Bcl-2 (Kurschner et al., 1995); the synaptic vesicle marker 
synapsin 1, the adaptor protein Grb2 and the prion interactor 1 (PINT1) (Spielhaupter et al., 
2001), for which no function was determined; the cellular chaperone heat shock protein- Hsp 
60, Hsp 104 and GroEL (Edenhofer et al., 1996); the 37- kDa/67- kDa laminin receptor 
(Gauczynski et al., 2001; Hundt  et al., 2001). The interaction in yeast does not prove that this 
association exists in mammalian cells. In order to prove in vivo interaction of PrPC with other 
proteins, Co-IP was performed with recombinant and authentic proteins expressed in different 
mammalian cell lines. And all interactions were confirmed independently of yeast.    
     PrPC also binds to Nrf2 transcription factor (NF-E2 related factor) and Aplp1 (amyloid 
precursor like protein) (Yehiely et al., 1997); different therapeutics (reviewed by Gauczynski 
et al., 2001); dystroglycan complex and synaptophysin, a synaptic vesicle protein (Keshet et 
al., 2000); laminin in PC 12 cells and rodent primary neurons, and this interaction promotes 
neurite growth in these cells (Graner et al., 2000). Caveolin-1 a principal component of the 
caveolar coat and a regulator of caveolae-dependent signaling and endocytosis binds to prion 
protein and FYN kinase in neuronal cells (Massimino et al., 2002; Mouillet-Richard et al., 
2000); CBP70 molecule (nuclear lectin-carbohydrate binding protein (CBP), most of witch 
are plurifunctional and regulates various physiological activities) co-localizes with PrP in the 
nucleus of NB4 cells. Immunoprecipitation revealed that these proteins are co-precipitated 
with PrPC, and interact via sugar dependent binding moiety (Rybner et al., 2002). By using an 
in situ crosslinking method that maintains the microenvironment of PrPPC Schmitt-Ulms and 
colleagues (Schmitt-Ulms et al., 2001) demonstrated that neural cell adhesion molecules, N-
CAMs, interact with prion protein and that the interaction occurs through the amino acid side 
chains, since enzymatic removal of N- linked sugar moieties did not disrupt the complexes. 
Nuclear riboprotein A2/B1 (functions in various aspects of RNA metabolism) and aldolase C 
are also proteins that interact with prion protein in vivo and vitro (Strom et al., 2006).  
Aldolase is an enzyme which catalyses the aldol reaction: the substrate, fructose 1.6-
bisphosphate (F-1.6-BP) is broken down into glyceraldehyde 3-phosphate and 
dihydroxyacetone phosphate (this reaction is a part of glycolysis).     
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Table 2: Proteins interacting with cellular PrP 
 Molecule Function Possible 
binding site 
Method of 
identification 
Aldolase C Enzyme(aldolase 
reaction) 
(*) Protein overlay assay 
Aplp1 Regulation of 
neurite growth 
Cell surface PrP-AP screening 
Bcl2 Apoptosis (*) Yeast-Two-Hybrid 
screening 
Caveolin 1 Signaling Caveolae raft Antibody-mediated 
cross linking 
CBP70 Plurifunctional Nucleus Immuniprecipitation 
Dystroglycan 
complex 
Links 
excracellular 
matrix to 
cutoskeleton 
Cell surface Detergent-dependent 
immunoprecipitation 
FYN kinase Enzyme(transfer 
of phosphate) 
(*) Antibody-mediated 
cross linking 
GFAP protective 
barrier in the cell
(*) Ligand blots 
Grb2 Intracellular 
signal 
transduction 
Intracellular 
vesicles 
Yeast-Two-Hybrid 
screening 
GroEL Chaperone (*) Yeast-Two-Hybrid 
screening 
Hsp60 Chaperone (*) Yeast-Two-Hybrid 
screening 
Laminin Neurogenesis Cell surface Ligand radiolabeling 
Laminin receptor 
(37/67 kDa) 
Laminin binding Cell surface Different assays 
N-CAMs Adhesion Caveolae-like 
domain 
Formaldehyde cross 
linking 
Nrf2 (Transcription 
factor) 
Apoptosis 
inhibitor 
Unknown PrP-AP screening 
Nuclear riboprotein 
A2/B1 
RNA binding (*) Protein overlay assay 
PINT1 Unknown Unknown Yeast-Two-Hybrid 
screening 
pli 110 (*) (*) Ligans blots 
STI1 HSP related Cell surface Complementary 
hydrophaty 
Synapsin Ib Regulation of 
neurotransmitter 
Intracellular 
vesicles 
Yeast-Two-Hybrid 
screening 
(*)   no information given  
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     Finally, complementary hydropathy, a technique that lets to generate a hypothetical 
molecule which is a complementary mirror image of the target protein, identified a 66 kDa 
protein, the stress inducible protein STI-1, with binds to PrPC on the cell surface and may be 
involved in neuroprotection (Martins, 1999; Zanata et al., 2002). 
 
2. PINT, a possible prion interactor 
  
     The only evidence that the PINT protein (also called PRNPIP) might interact with cellular 
prion protein was published by Spielhaupter and co-workers (Spielhaupter et al., 2001). 
Initially, they used yeast-two-hybrid screen based on Gal4 system. Murine PrPC (amino acids 
23-231) was fused in the frame to Gal4-binding domain as bait to search a mouse brain cDNA 
expression library fused to the Gal4-transactivation domain, and several interaction partners 
were sequenced and identified. One of them, not characterized before, was named PINT1 
(prion interactor 1).  
     To confirm the interaction of the PINT1 with PrP by a method completely unrelated to the 
yeast interaction trap, Spielhaupter and co-workers used a vaccinia virus-based expression 
system in mammalian cells. The interaction led to high expression of the desired protein in the 
cytoplasm. Lysates were subjected to co-immunoprecipitation and the co-precipitated PrP was 
detected by immunoblot.  
     For detection of a possible region of interaction, PINT1 was subjected to binding assay 
with two truncated constructs of PrP (N-terminal construct (amino acids 23-100) and C-
terminal construct (amino acids 90-231)), and the ability to interact was tested in BHK cells 
by co-immunoprecipitation. Results revealed that PINT1 interacts just with C-terminal part of 
prion protein.  
     To identify the organs where PINT1 is expressed, Spielhaupter and colleagues examined 
an mRNA dot blot representing different murine tissues by probing it with a PINT1 DNA 
fragment. A strong expression was detectable in brain as well as in heart, thyroid, and testis. 
A faint signal was visible in muscle cells, liver, pancreas, and kidney. No transcripts were 
detectable in embryonic development stages and in ovary, uterus, eye, lung, and spleen. The 
tissue distribution of PrP mRNA has been published previously by Yehiely and colleagues 
(Yehiely et al., 1997). They reported a high expression of PrPC in brain, lung, kidney, and 
heart, and a weaker expression was seen in liver, spleen, and some other organs. The pattern 
of PINT expression partially overlaps with the known mRNA tissue distribution of PrPC 
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indicating co-expression of proteins in these organs, and that these two proteins physically 
can interact with each other. 
     The complete open reading frame of murine PINT1 was not fully identified. Spielhaupter 
and colleagues were working with a part PINT1 of protein (120 amino acid long), which did 
not have an original start codon.  
 
2.1 Sequence of PINT protein 
 
     In the present study PINT protein cloned from sheep was studied. The sequence of this 
protein is presented in Figure 2. PINT from sheep is a 259 amino acid protein with size of 
about 30 kDa. This protein has a very similar sequence to the homologous from man, rat and 
mouse (Figure 2): prion protein interacting protein from man shows 99% sequence similarity 
(has 2 substitutions), rat protein shows 98% sequence similarity (with 4 substitutions) and 
mouse PRNPIP1 has 97% sequence similarity (7 substitutions) relative to PINT protein from 
sheep. The sequence has a striking similarity to some other hypothetical proteins from 
chimpanzee and rhesus monkey, which have an additional 28 amino acid sequence and one 
amino acid substitution at the position 58 (data not shown) (for distance tree of homologous 
proteins see Appendix 4).  
     PINT protein contains several conserved domains, which are common to variety of 
proteins (Figure 3). 
     Exonuc_X-T conserved domain is common to different exonucleases. This family includes 
a variety of exonuclease proteins, such as ribonuclease T (ribonuclease is a nuclease that 
catalyzes the breakdown of RNA into smaller components. They can be divided into 
endonucleases and exonucleases. RNase T is an exoribonuclease that initiates attack at the 3' 
hydroxyl terminus of tRNA and releases AMP in a random mode of hydrolysis. The possible 
involvement of RNase T in end-turnover of tRNA and in RNA metabolism in general is 
discussed by Deutscher and colleagues (Deutscher et al., 1984)) and the epsilon subunit of 
DNA polymerase III (main prokaryotic polymerase that are responsible for DNA elongation). 
     EXOIII is an exonuclease domain in DNA-polymerase alpha and epsilon chain, 
ribonuclease T and other exonucleases (exonucleases are enzymes that cleave nucleotides one 
at a time from an end of a polynucleotide chain. These enzymes hydrolyze phosphodiester 
bonds from either the 3'- or 5'-terminus of polynucleotide molecules).  
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     KapD domain, also found in inhibitor of the KinA pathway to sporulation, is predicted 
exonuclease. 
      PolC is alpha subunit of DNA polymerase III (gram-positive type), responsible for DNA 
replication, recombination, and repair.  
     DNAQ- DNA polymerase III, epsilon subunit and related 3'-5' exonucleases, takes part in 
DNA replication, recombination, and repair. 
     PINT protein sequence shows 30%-40% similarity to different nucleases (exoribonuclease, 
DNA polymerase and others). It is likely that the PINT protein might also have nuclease 
activity, but this has to be confirmed by further studies.   
 
 
A) PINT reading frame (sheep) 
 
1   MLAPLQTGAA RFSSYLLSRA RKVLGSHLFS PCGVPEFCSI STRKLAAHSF GASMAAMMSF  60 
61  PPQRYHYFLV LDFEATCDKP QIHPQEIIEF PILKLNGRTM EIESTFHMYV QPVVHPQLTP  120     
121 FCTELTGIIQ AMVDGQPSLQ QVLERVDEWM AKEGLLDPNV KSIFVTCGDW DLKVMLPGQC  180 
181 QYLGLPVADY FKQWINLKKA YSFAMGCWPK NGLLDMNKGL SLQHIGRPHS GIDDCKNIAN  240              
241 IMKTLAYRGF IFKQTSKPF  259 
             
B) Alignment of homologous regions  
 
PINT: MLAPLQTGAA RFSSYLLSRA RKVLGSHLFS PCGVPEFCSI STRKLAAHSF GASMAAMMSF 60 
(SHEEP)      
MAN : ********** ********** ********** ********** ********G* *******V** 60  
RAT : ********** ********** ********** ********** ********G* *******VP* 316 
MOUSE:********** ********** ********L* ******L*** ********G* **A****VP* 65 
 
PINT: PPQRYHYFLV LDFEATCDKP QIHPQEIIEF PILKLNGRTM EIESTFHMYV QPVVHPQLTP 120 
(SHEEP)  
MAN : ********** ********** ********** ********** ********** ********** 120  
RAT : ********** ********** ********** ********** ********** ********** 376 
MOUSE:********** ********** ********** ********** ********** ********** 125 
 
PINT: FCTELTGIIQ AMVDGQPSLQ QVLERVDEWM AKEGLLDPNV KSIFVTCGDW DLKVMLPGQC 180 
(SHEEP)             
MAN : ********** ********** ********** ********** ********** ********** 180 
RAT : ********** ********** ********** ********** ********** ********** 436 
MOUSE:********** ********** ********** ********** ********** ********** 185 
 
PINT: QYLGLPVADY……….259 
(SHEEP) 
MAN : **********……….259 
RAT : H*********……….515 
MOUSE:H*********……….264 
 
 
Figure 2: Animo acid sequence of PINT (A) and alignments (B) (data from NCBI blast). 
* indicates identical amino acids (for one letter symbols of amino acids see Appendix 5). 
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Figure 3: Conserved domains found in PINT protein (data from NCBI blast). 
 
2.2 Alternative splicing (in general) 
 
     Alternative splicing is the process that occurs in eukaryotes in which the splicing process 
of a pre-mRNA transcribed from one gene can lead to different mature mRNA molecules and 
therefore to different gene products with various functions. When the pre-mRNA has been 
transcribed from the DNA, it includes several introns (sections of DNA that will be spliced 
out after transcription) and exons (any region of DNA within a gene, which is transcribed to 
the final messenger RNA (mRNA) molecule).  But introns and exons are not yet determined 
at this stage. This decision is made during the splicing process. The types of alternative 
splicing alteration that have been observed include constitutive splicing, exon skipping, intron 
retention, manually exclusive exons, and alternative 5' and 3' splice sites (Figure 4). Brett and 
colleagues (Brett et al., 2002) showed that among several eukaryotes the amount of alternative 
splicing is comparable, with no larger differences between humans and other animals.  
 
 
Figure 4: Types of alternative splicing (taken from http://lexikon.freenet.de/Alternatives_Splicing)  
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2.3 Splicing forms and polymorphism of PINT1 gene 
 
     Different splicing forms of sheep and human genes are presented in Figure 5. The human 
gene has at least ten exons, the ovine gene has at least nine exons. The mRNAs in both 
species show a high degree of differential splicing. The high degree of conservation of exonic 
nucleotide sequences enables mapping of sheep exons onto the human gene sequence. Most 
of the sheep cDNA sequences map exactly to tentative human exons. There are homologies 
between transcripts II & IV and I & VI. The main difference is that sheep exon 1 is small, 
only 29 bp, and is included in the tentative human exon 1a, but with a consensus splice donor 
site in the 3’ flank. Two of the cDNA variants of sheep give rise to the same protein 
(transcripts IV and V) (this protein was used in the present study), while the third (transcript 
VI) code for a truncated version. Both protein variants correspond to variants described in 
man, cow and dog. All currently known mRNAs encode part or the entire putative PrP 
binding site, encoded in sheep by exons 4 to 7.   
 
 
 
Figure 5: Gene structure of human and sheep PINT1 gene (modified, (Gilliland, et al., 
2006)). (Blue, exons; yellow, open reading frame).  
 
 
     Gilliland and coworkers (Gilliland et al., 2006) also demonstrated polymorphisms in ovine 
PINT1 gene. Two polymorphisms were detected in intron 6 at positions -233 (G/A) and -115 
(G/A).  
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3. Affinity tags 
 
     Expression of recombinant proteins is a standard, widely used technique in molecular 
biology. The limiting steps in this technique usually are synthesis of proteins which are poorly 
translated in the host cell, and purification of active and correctly folded recombinant protein 
of interest. In order to make this procedure easier different affinity tags are used. 
  
     Affinity tags can be divided into two groups according to their size: small affinity tags 
(His6, Arg5, FLAG) and large tags (glutathione-S-transferase (GST), maltose binding protein 
(MBP), gb1 domain of protein G (GB1), different fluorescent proteins).  
     The procedure of tagging with large tags is quite simple: a gene encoding for a large tag 
protein is fused in frame to the gene encoding the protein of interest (either to the N- or C-
terminus) and the resulting chimera is expressed in different cell lines (Baneyx, 1999). Often 
wild type tag proteins have to be modified by introducing different substitutions in order to 
engineer a tag protein with the best characteristics (Bevis et al., 2002; Zolotukhin et al., 
1996). 
     Small tags are often introduced in the cDNA using either PCR or insertion into an existing 
expression vector using a small fragment encoding the tag (Schmitt et al., 1993).  
     Several cloning vectors for different expression systems are available (Qiagen, Invitrogen). 
Vectors are designed to permit fusion of a small or large tag (to both termini) with or without 
a protease cleavage site, which allows the removal of the foreign amino acids. 
 
     In addition to their obvious utility in protein purification, affinity tags have also been 
observed to have many other positive affects on proteins they are fused with. Tags may 
improve the yield of recombinant proteins (Nilsson et al., 1997); help to protect them from 
intracellular proteolysis (Nilsson et al., 1997; Smyth et al., 2003), and influence crystal 
formation (Bucher et al., 2002). Bucher and colleagues demonstrated the effect of affinity tags 
on crystallization of Pyrococcuc furiosus maltodextrin-binding protein and on its ability to 
diffract X-rays. The amino acid sequence of the tag seems to have major effect on both, 
crystal formation and X-ray diffraction; small tags interfere less with crystal formation than 
large tags. Tags can help to synthesize otherwise poorly translated polypeptides (Baneyx, 
1999). Fusion proteins may also enhance the solubility of whole chimera (Hammarstrom et 
al., 2002; Nilsson et al., 1997; Smyth et al., 2003). Hammarstrom and colleagues showed that 
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large fusion proteins may increase expression and solubility of the protein. They tested how 
different tags (His6, GST, NusA, ZZ, GB1, MBP and thioredoxin (TRX)) affect the solubility 
of small human proteins (only the His6 tag did not have any positive effect). Solubilisation of 
inclusion bodies and then refolding of protein in order to get active product can be a very 
difficult task to do. The best way out of this problem is to make a fusion to a protein that is 
known to have high solubility.  
     However, affinity tags have a potential to interfere with the biological activity of the target 
protein. Large tags can decrease crystal growth (Smyth et al., 2003), and affect cellular 
localization (Campbell et al., 2002). Removal of large tags is almost always necessary, but it 
requires expensive proteases and can cause precipitation of protein (Baneyx 1999) or 
formation of inactive product (Baneyx 1999; Bucher et al., 2002). Cleavage is rarely 
complete, this leads to reduction in yields; additional steps may be required to obtain active 
products, and solubility is newer guaranteed. Overexpression leads to the disappearance of 
signal and can be also toxic to the host cell.     
     To decide which tag to use, is an important decision which can influence the results of 
different assays. Large tags offer an advantage over a small tag when expressing soluble and 
active recombinant proteins, but small tags often improve purification. Fluorescent tags help 
to verify successful transfection, to report gene expression, and to monitor the subcellular 
localization of protein.  
 
3.1 Histidine tag (His6) 
 
     His6 (sequence: HHHHHH) is one of the smallest tags used in molecular biology. The 
biggest advantage of this tag is that His6  can be used in immobilized metal-affinity 
chromatography (IMAC) (Arnold, 1991), which is based on interactions between chelated 
metals (usually Ni2+, Zn2+, Cu2+, Fe3+) and the side chains of  Glu, Tyr, Cys, His, Arg, Lys, 
Asp, and Met. Metals are chelated by iminodiacetate (IDA; has three chelating sites), 
nitrilotriacetic acid (NTA; has four chelating sites) and some other substances.  
     The most popular ligand for His6 tag is Ni-NTA (Arnold 1991; Schmitt et al., 1993). (This 
ligand was also used in the present study).  NTA has four chelating sites, which allow a stable 
interaction between Ni+ and column matrix leaving two metal coordination sites free to 
interact with functional groups of protein. Bound proteins are eluted from the resign by the 
displacement with another metal binding ligand, such as imidazole (when protein purification 
 - 25 -
is performed under native conditions), or by protonation of the active amino acid side chains 
by changing pH (denaturing conditions). 
     Metal chelate affinity chromatography using Ni-NTA resin offers a number of advantages: 
cysteine is relatively rare amino acid, so unspecific interactions are atypical; very diluted 
solutions of proteins can be used (Schmitt et al., 1993); purification under native conditions 
preserves protein-protein interactions allowing studies of bindings partners; the His6 tag 
usually do not interact with the activity of the protein (Janknecht et al., 1991; Janknecht et al., 
1992; Schmitt et al., 1993); quantitative binding and elution of tagged protein is possible; and 
denaturing conditions can be also used (if the tag is inaccessible from the surface) (Nilsson et 
al., 1997).  
     Metal chelate affinity chromatography also has some limitations (Arnold, 1991): proteins 
bind to column according to the number of accessible His (two histidines separated by three 
amino acids in an α- helix exhibit a very high affinity for metals); proteins may not interact 
with the resign in its native form (when folded, tag lies inside the structure); certain proteins 
have a high affinity for the column and needs higher concentration of imidazole for elution. 
 
3.2 Red fluorescent protein (DsRed) 
 
     DsRed, a bright red fluorescent protein cloned from the coral Discosoma, is a 28 kDa 
polypeptide. The wild type of this protein has broad excitation and emission bands with 
maxima at 558 and 583 nm, respectively, with a minor peak at 494 nm and a significant 
tryptophan peak at 280 nm (Yarbrough et al., 2001) (Figure 9 in Materials and Methods).  
     DsRed display many properties of great utility for cell biological studies: protein exhibits a 
bright red signal; fluorescence emission is separable from GFP; the absorbance and 
fluorescence signals remain unchanged at pH from 5 to 12 and are relatively resistant to 
photobleaching (Baird et al., 2000). At the same time this protein has a number of negative 
characteristics, such as slow maturation (takes several days to mature at room temperature 
(Baird et al., 2000; Yarbrough et al., 2001)), incomplete chromophore formation and an 
mandatory green-emitting intermediate (Baird et al., 2000), and obligatory oligomerization in 
vitro and in living cells (Baird et al., 2000; Campbell et al., 2002) followed by further 
aggregation (Robinson et al., 2005). Campbell and colleagues (Campbell et al., 2002) showed 
that wild type DsRed exists as monomer (32 kDa), but at higher concentrations tends to form 
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dimers (60 kDa), and tetramers (120 kDa); at very high concentrations DsRed might form 
even octamers (Baird et al., 2000).   
 
     An important question is to what extent oligomerization affects transport and folding of the 
tagged proteins. Unlike the case of GFP, proteins tagged with DsRed are often found to 
aggregate within the cell.  Aggregation is caused by strong tendency of tetramerization and 
not by the proteins this fluorescent tag is fused with (Lauf et al., 2001). At the same time, 
some studies reported that the influence of both EGFP and DsRed on transport and 
localization is minimal: transport of the cell envelope proteins E1 and E2 of rubella virus in 
BHK cells, was not influenced by these tags (Ojala et al., 2004), and no effect on Epstein-barr 
virus membrane protein B2 was either reported (Lynch et al., 2002). 
 
     In order to change some of characteristics, several DsRed mutants were created (mutant, 
which was used in the present study, is called DsRed-Express). In some cases just one 
substitution can cause mutant to mature much faster if compared to wild type protein 
(Robinson et al., 2005); by introduction of more substitutions mutants with increased 
solubility and decreased level of residual green emission were formed (Baneyx  1999; 
Robinson et al., 2005). 
 
3.3 Green fluorescent protein (GFP) 
 
     Wild type GFP is a spontaneously fluorescent protein isolated from Pacific jellyfish, 
Aequorea Victoria, a 238 amino acid protein with excitation and emission maxima at 395 and 
508 nm, respectively, with a minor excitation peak at 475 nm (Yang et al., 1996) (Figure 9 in 
Materials and Methods).  
     Wild type GFP can form dimers in some crystals (Yang et al., 1996) or in solution at high 
protein concentration (Tsien, 1998) (it is not known if dimers appear under physiological 
conditions). GFP is one of the most often used fluorescent tag because of its minimal toxicity 
to the cell (Billinton et al., 2001), and stability (if matured properly at low temperature this tag 
is stable and fluorescent at temperature up to 65 °C, while, higher temperature causes 
denaturation); loses fluorescent signal disappears just at very high pH (11-12) (Tsien, 1998). 
GFP was successfully fused and targeted to different organelles all over the cell (reviewed by 
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Tsien, 1998). This tag is very resistant to denaturation, partial or near total renaturation is 
achieved after removal of denaturing conditions (Yang et al., 1996).  
     Although native GFP produces significant fluorescence and is extremely stable, the 
excitation maximum is close to the ultraviolet range. Because UV light requires special 
optical considerations and can damage living cells, it is generally not well suited for live cell 
imaging with optical microscopy. Another problem working with wild type GFP is 
autofluorescence, which contaminates the GFP signal (cellular metabolites, flavins, 
NAD(P)H, lipofuscins, protoporphyrin IX causes autofluorescence in the cell (Billinton et al., 
2001)). In order to solve all these problems, several GFP mutants were created. The excitation 
maximum of GFP is readily shifted to 488 nm by introducing a single point mutation. This 
mutation is featured in the most popular variant of GFP, termed enhanced GFP (EGFP; also 
used in the present study).  
 
4. The aim of this study 
 
     PINT is a new protein cloned from sheep that might be a prion protein binding partner. 
The only thing known about this protein is conserved nuclease domain and possible nuclease 
activity (data from protein sequence). 
 
     The aim of the present study was: 
- to make three PINT constructs with different plasmids (pDsRed-Express-
N1, pZeoSV and pET16B); 
 
- to transform E.coli with pET-PINT and express PINT protein in bacterial 
cells; purify and analyze it; 
 
- to transfect different mammalian cell lines with pDsRed-Express-PINT and 
pZeoSv-PINT; and by using different assays learn as much as possible about 
PINT protein (cellular localization, behaviour in the cell and so on); 
 
- to co-transfect PINT and PrP in order to study co-localization of these 
proteins and possible interaction.  
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II. Materials and methods 
 
     Each method and some related theory is presented in brief, followed by a short protocol. 
Plasmid maps, list of reagents and their manufacturers, different buffers and media used in 
this work are presented in the Appendix 1-3, respectively.  
 
1. General techniques for working with DNA and bacterial cultures 
 
     The purpose of the first part of this study was to make three different PINT constructs by 
running polymerase chain reaction (PCR), cutting and ligating vectors and PCR products, 
multiply and isolate them. Later these constructs were used for transformation of E.coli or 
transfection of mammalian cells in order to express PINT protein.  
 
1.1 DNA constructs 
 
     The primers used in cloning of PINT constructs are listed in Table 3. In this study three 
different constructs were made: pDsRed-Express-PINT, pZeoSv-PINT and pET-PINT. Those 
constructs were later used for expression of PINT in E.coli (construct pET-PINT) and for 
transfection into mammalian cells (constructs pDsRed-Express-PINT and pZeoSv-PINT). All 
plasmids were sequenced to confirm correct amplification and cloning. Primers used for 
sequencing are presented in Table 3.  
 
     The pDsred-Express-N1 vector (Appendix 1) is a mammalian expression vector (4700 bp) 
that contains a gene for canamycin resistance and encodes DsRed-Express, a variant of 
Discosoma sp. red fluorescent protein. DsRed-Express contains nine amino acid substitutions, 
which improve the solubility of the protein and reduce the time from transfection to detection 
of red fluorescence (the native form of this protein is not very soluble and has a long 
maturation time (Campbell et al., 2002)). In addition, these substitutions reduce the level of 
residual green emission (Bevis et al., 2002). When DsRed-Express is expressed in mammalian 
cell cultures, red-emitting cells can be detected by either fluorescence microscopy or flow 
cytometry 8–12 hours after transfection (DsRed-Express excitation and emission maxima is at 
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557 nm and 579 nm, respectively). For more information about this vector see 
www.bdbiosciences.com. 
 
      The pZeoSv vector (Appendix 1) is a constitutive mammalian expression vector (3500 bp) 
containing a gene that confers resistance to the novel antibiotic zeocin, which can be used to 
select for the pZeoSv vector in bacterial and mammalian cells. Genes cloned into this vector 
are expressed from the Simian Virus 40 (SV40) early enhancer/promoter for high level 
transient and stable expression in mammalian cell lines. For more information about this 
vector see www.invitrogen.com. 
 
     The pET system is a powerful system for the cloning and expression of recombinant 
proteins in E.coli. Target genes are cloned in pET plasmids under control of strong 
bacteriophage T7 transcription and translation signals. Once established in a non-expression 
host, target protein expression may be initiated by transferring the plasmid into an expression 
host containing a chromosomal copy of T7 RNA polymerase under control of the lac Z 
promoter. Expression is then induced by adding IPTG to the bacterial culture; and the desired 
product can comprise more than 50% of the total cell protein a few hours after induction. 
Another important benefit of this system is its ability to maintain target genes transcriptionally 
silent in the uninduced state. 
     The pET-16b vector (5711 bp) (Appendix 1) carries an N-terminal His-tag sequence 
followed by Factor Xa site (protease site) and three cloning sites. For more information about 
this vector see www.novagen.com. 
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Table 3. Primers used in PCR and sequencing 
 Primers Sequence Restriction
enzymes 
1 PINTRedF 5'- GATGCTTCTAGATCTCAATGCTAGCACCT-3' BglII 
2 PINTRedR 5'- TCCTCAGGATCCCCGAACGGCTTTGACGT-3'  BamHI 
3 PINT-Z-F 5'- GGCTTTCCACCGGTCACTGAACCT-3' AgeI 
4 PINT-Z-R 5'-CTCATCACGCGTCAATGATGATGATGATGATG 
GAACGGCTTTGACGT-3' 
MluI 
5 PINTlongF 5'-TGGATGTCATATGCTAGCACCTTTACAGACT-3' NdeI 
6 PINT-pETcorrR 5'- GCAGCCGGATCCCTCAGAACGGCTTT-3' BamHI 
7 DsRedF 5'- TACGGTGGGAGGTCTATAT-3' 
8 DsRedR 5'- TCCATGCGCACCTTGAAGC-3' 
9 SP6 5'- CATTTAGGTGACACTATAG- 3' 
10 T3 5'- AATTAACCCTCACTAAAGGG- 3' 
11 T7promotor(F) 5'- TAATACGACTCAATATAGGG- 3' 
10 T7terminator(R) 5'- CTAGTTATTGCTCAGCGGT- 3' 
 
Forward (F) and reverse (R) primers used in the construction of PINT-expression plasmids (1-
6), primers used for sequencing  pDsRed-Express-PINT (7-8), primers used for sequencing 
pZeoSv-PINT (9-10) and primers used for sequencing pET-PINT (11-12). Restriction sites 
are indicated in bold. Sequence coding for 6xHis (in reverse) is underlined (4). All primers 
were produced by MWG-Biotech AG.   
 
1.1.1 Polymerase chain reaction (PCR) 
 
     The PCR method enables amplification of nucleic acid sequence fragments in vitro by 
primer extension (Vosberg, 1989). This can be a single gene, or just a part of a gene. As 
opposed to living organisms, the PCR process can copy only short DNA fragments, usually 
up to 40 kb. The PCR process usually consists of a series of 20 to 35 cycles. Each cycle 
consists of three major steps. The double-stranded DNA has to be heated at 94-96 °C (or 98°C 
if extremely thermostable polymerases are used) in order to separate the strands. This step is 
called denaturing. It breaks apart the hydrogen bonds that connect the two DNA strands. Prior 
to the first cycle, the DNA is often denatured for an extended time to ensure that both the 
template DNA ant the primers have completely separated and are now single-stranded. After 
separating the DNA strands, the temperature is lowered, so the primers can hybridize to the 
single template DNA strands. This step is called annealing. The temperature of this stage 
depends on the primers and is usually 5 °C below their melting temperature (45-60 °C). 
Finally, the DNA polymerase has to copy the DNA strands. It starts at the annealed primer 
and works its way along the DNA strand. This step is called elongation. The elongation 
temperature depends on the DNA polymerase that was used in the reaction. 
 
 - 31 -
     In this study all polymerase chain reactions were performed as followed:  
 
5x Phusion HF buffer                                   10 μl 
2 mM dNTP                                                  5 μl 
Forward and reverse primers                        0.25 pmol (each) 
Template DNA                                              10 ng (max) 
Phusion DNA polymerase                             0.5 μl 
H2O                                                                to the end volume of 50 μl 
 
     Reaction conditions are presented in Table 4.  
 
 
Table 4. PCR conditions 
Name of the step Temperature (°C) Time (sec) Repetitions 
First denaturing 98 30 1 
Denaturing 98 5 
Annealing 60* 30 
Elongation 72 30 
 
30 
Last elongation 72 600 1 
* annealing temperature was 55 °C in PCR amplification with PINT-Z-F and PINT-Z-R 
primers. 
 
1.1.2 Agarose Electrophoresis 
 
     Gel electrophoresis is a method that separates macromolecules (nucleic acids or proteins) 
on the basis of size, electric charge, and other physical properties. 
     Agarose gels are used for DNA separation. Agarose is a natural colloid extracted from sea 
weed, a linear polysaccharide (average molecular mass about 12.000) made up of the basic 
repeat unit agarobiose, which comprises alternating units of galactose and 3.6-
anhydrogalactose.  
     An agarose gel is loaded with the DNA fragments and current is passed through the gel. 
Since DNA is negatively charged, it will migrate towards the positive pole. The DNA will not 
migrate at the same rate, however. Larger pieces of DNA collide with the gel matrix more 
often and are slowed down, while smaller pieces of DNA move through more quickly. By 
using gels with different concentrations of Agarose (1-3%), one can resolve different sizes of 
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DNA fragments. Higher concentrations of agarose facilitate separation of small DNAs, while 
lower concentrations allow resolution of larger DNAs.   
 
     In the present study agarose was used at the concentration of 1%. Agarose gels were 
formed by suspending dry agarose in 1x TAE buffer, then autoclaving the mixture (for 20 min 
at 120 °C) to melt agarose. Mixture was poured into forms, added ethidium bromide (a potent 
mutagen, fluorescent dye that intercalates between bases of nucleic acids and allows very 
convenient detection of DNA fragments at UV light) and allowed to cool at room temperature 
to form a rigid gel (to make one gel, 50 ml 1% agarose were added 5 μl ethidium bromide 
solution (1% in water)). Gel was loaded with DNA samples mixed with 6x Mass Ruler 
Loading Dye Solution and current were passed through it (100 V) for about 1hour, using 1x 
TAE as electrophoresis  buffer. Different standard DNA ladders (Appendix 2) were used to 
estimate the sizes of DNA fragments. 
  
1.1.3 Purification of DNA from agarose gel slices 
 
     Isolation of DNA fragments from agarose gel slices was performed using 2 kits: Geneclean 
Spin Kit from Q-Bio Gene (while working with pDsRed-Express-PINT construct) and 
E.Z.N.A Gel Extraction Kit from Omega Bio-tek (while working with pZeoSv-PINT and 
pET-PINT constructs).  
     In general, both kits are based on the same principle, just a little bit different columns and 
buffers are used: DNA binds to a silica-based membrane at high concentrations of salt, is 
washed a few times to get rid of various impurities and is eluted when the salt concentration is 
lowered. The fact that DNA binds in high salt and elutes in low salt makes this method 
especially useful as a purification procedure. DNA is eluted with either water or a low salt 
buffer. For detailed protocols, consult the manufacturer's handbooks. 
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1.1.4 Cutting of DNA with restriction enzymes 
 
     A restriction enzyme is an enzyme that cuts double-stranded DNA. The enzyme makes two 
incisions, one through each of the phosphate backbones of the double helix without damaging 
the bases.  Rather than cutting DNA indiscriminately, a restriction enzyme cuts only double-
helical segments that contain a particular nucleotide sequence, and it makes its incisions only 
within that sequence, known as a "recognition sequence", always in the same way. Some 
enzymes make strand incisions immediately opposite one another, producing "blunt end" 
DNA fragments. Most enzymes make slightly staggered incisions, resulting in "sticky ends", 
out of which one strand protrudes. 
 
     All restriction enzymes used in this study (Table 3) for making the PINT constructs 
produce "sticky ends". It was possible to cut with two restriction enzymes at the same time by 
choosing a suitable buffer. Enzymes and suitable buffers are presented in Table 5. 
     Restriction enzyme cutting reactions were performed as followed: 
 
10x buffer                                                      5 μl   
DNA (PCR-product or vector)                       0.5-1 μg 
Restriction enzyme 1 and 2                            1 μl (each) 
H2O                                                                to the end volume of 50 μl 
  
     Reaction mix was incubated at 37 °C for one hour. 
 
 
Table 5. Restriction enzymes and buffers  
Name of the construct Restriction enzymes Buffer 
BglII pDsRed-Express-PINT 
BamHI 
10x BamHI buffer 
AgeI pZeoSv-PINT 
MluI 
10x R-buffer with BSA 
NdeI pET-PINT 
BamHI 
10x R-buffer with BSA 
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1.1.5 Ligation of DNA fragments 
 
     The enzyme used to ligate DNA fragments is T4 DNA ligase, which originates from the 
T4 bacteriophage. This enzyme will ligate DNA fragments having overhanging, cohesive 
ends that are annealed together, as well as blunt-ended fragments. A ligation reaction requires 
three ingredients in addition to water: two or more fragments of DNA that have either blunt or 
compatible cohesive ("sticky") ends, buffer which contains ATP, and T4 DNA ligase. A 
typical reaction for inserting a fragment into a plasmid vector (subcloning) would utilize 
about 0.01 (sticky ends) to 1 (blunt ends) units of ligase. 
 
     Ligation reactions were performed as followed: 
 
2x Rapid ligation buffer                                                                    5 μl 
Vector cutted with restriction enzymes                                            50 ng 
PINT-fragment cutted with the same restriction enzymes               35 ng 
T4 DNA ligase                                                                                  1 μl 
H2O                                                                                                   to the end volume of 10 μl 
 
     Reaction mix was incubated at 16 °C over night or at RT for 2-3 hours.  
Before the transformation of E.coli T4 DNA ligase was inactivated by heating reaction mix at 
70 °C for 15 min.  
 
1.2 Transformation of E.coli  
 
     Among many systems available for heterologous protein production, the gram-negative 
bacterium Escherichia coli remains one of the most attractive because of its ability to grow 
rapidly and at high density, its well characterized genetics, and the availability of large 
number of cloning vectors and mutant host strains. 
     Transformation is the process of getting the recombinant vector from a reaction mixture or 
vector solution into E. coli cells. To enable the cells to take up circular vector DNA they have 
to be made competent. Competent cells are cells which can accept extra-chromosomal DNA 
or plasmids. Cells can be made competent by chemical treatment or by transfer to a salt-free 
medium for electroporation. The method for the preparation of competent cells depends on 
the transformation method used and transformation efficiency required. 
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     The choice of the E. coli host strain depends on the goal of the transformation. The 
transformation of a vector for multiplication should be done in a recA- strain, such as 
DH5α, NovaBlue or XL1-Blue. The transformation of a vector for protein expression should 
be done in the appropriate expression host too (BL21(DE3)LysS, AD94(DE3)LysS or others). 
 
     In this study E.coli strain DH5α was used for multiplication of plasmids. Simple and 
efficient method for making these cells competent was published by Inoue and co-workers 
(Inoue et al, 1990). 
     For expression of PINT protein E.coli strain BL21(DE 3)LysS was used. BL21 cells 
produces lower levels of proteases and thus are more suitable for expression of recombinant 
proteins, and also contain a T7 RNA polymerase gene under control of a lac promoter. Prior 
transformation of plasmid into BL21 cells, plasmid was multiplied in non-expressional host, 
DH5α cells.  
   
1.2.1 Transformation of competent DH5α competent E.coli cells  
 
     Competent DH5α E.coli cells (these cells are quite stable and can be stored in a competent 
state at -80 °C) were thawed on ice. 50-100 µl of cell suspension was added 2 μl of ligation 
reaction mix and cells stayed on ice for 30 min. After that cells were given a heat shock at 
42°C for 45 sec. Then cells were left to stay on ice for 5 more minutes and streaked out on 
preheated LB-plates with suitable antibiotic (different PINT expression plasmids and suitable 
media with antibiotic for growing over night cultures or making plates are presented in Table 
6). Plates were incubated at 37 °C over night. 
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Table 6. PINT expression plasmids, media and antibiotics 
Expression 
plasmid 
E.coli 
strain 
Medium Antibiotic (concentration) Purpose of 
the cells 
pDsRed-
Express-PINT 
DH5α LB, high salt Canamycin(50 μg/ml) Multiplication 
of plasmid 
pZeoSv-PINT DH5α LB, low salt Zeocin(50 μg/ml) Multiplication 
of plasmid 
DH5α LB, high salt Ampicilin(50 μg/ml) Multiplication 
of plasmid 
pET-PINT 
BL21(DE3) 
LysS 
LB, high salt Ampicilin/ 
Chloramphenicol 
(50/20 μg/ml) 
Expression of 
recombinant 
protein 
 
1.2.2 CaCl2 method for making competent BL21 cells 
 
     Before each transformation BL21(DE 3)LysS  E.coli cells have to be made competent by 
CaCl2 treatment, since the Inoue method used for DH5α does not work on these cells.  
     BL21(DE3)LysS cells (frozen) were streaked out on LB/Chl (50 μg/ml) plate (this E.coli 
strain has chloramphenicol resistance gene (chlr) on LysS plasmid) and incubated over night 
at 37 °C. Next day some colonies that were formed on the plate were inoculated in 100 ml 
LB/Chl medium until OD550 reached about 0.05-0.1; cells were grown to OD550 about 0.3 and 
were incubated on ice for 10 min. After that, the cells were spinned down at 5000x g for 10 
min at 4 °C and supernatant was removed, while the cell pellet were resuspended in 20 ml 
cold 100 mM CaCl2 solution. After staying on ice for 5 min cells were spinned down one 
more time and resuspended in 4 ml of cold CaCl2 solution; cells were left to stay on ice for 
minimum one hour, eventually over night (the longer they stay on ice, the more competent 
they become). 200 μl of cell suspension was used for each transfection.  
 
1.2.3 Transformation of competent BL21(DE3)LysS E.coli cells 
 
     To 200 μl of competent BL21(DE3)LysS cells were added 50 ng of plasmid, and cells 
were incubated on ice for 30 min. After that cells were given a heat shock at 42 °C for 45 sec. 
Then cells were left to stay on ice for 2 more minutes, added 800 μl LB-medium and 2μl 
sterile 2 M glucose, mixture was incubated at 37 °C for 30min. Cells were streaked out on 
LB/Amp/Chl plates and incubated over night at 37 °C.  
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1.3 Isolation of multiplied DNA  
 
     For isolation of plasmid DNA two different kits were used: Wizard Plus Sv Minipreps 
DNA Purification System from Promega and Pure Yield Plasmid Midiprep System also from 
Promega (gives higher DNA concentration).  
    
     The silica-based Wizard Plus Minipreps DNA Purification System provides a simple and 
reliable method for rapid isolation of plasmid DNA, with no organic extractions or ethanol 
precipitations. This system can be used for isolation of any plasmid, but works most 
efficiently when the plasmid is < 20,000 bp. Isolation of DNA consists of a few main steps: 
making clear lysate (by sedimentation, resuspendation, lysis and neutralization of cell 
suspension. Alkaline protease solution are used for inactivation of endonucleases and other 
proteins that can affect the quality of isolated DNA), transfer of lysate on the column which 
binds DNA, wash of the column, removal of solution and elution of DNA in nuclease-free 
water. For detailed protocol see www.promega.com.   
  
     The Pure Yield Plasmid Midiprep System provides high-speed purification of plasmid 
DNA using a newly developed silica-membrane-based column. This design allows 
purification of 100–200 µg of plasmid DNA from 50 ml of bacterial culture. The method of 
isolation is similar to one described above, except that Endotoxin Removal Wash is used to 
reduce endotoxin, protein and RNA contamination, improving results for eukaryotic cell 
transfection; also improving in vitro transcription/translation reactions and fluorescent DNA 
sequencing. Elution is performed in a small volume of water, providing concentrated DNA for 
chosen application. In this study DNA purification by centrifugation was performed. For a 
detailed protocol see www.promega.com.  
 
1.4 Quick-check of plasmid-containing cells 
 
     In order to quick-check the size of E.coli plasmids, the procedure described by Akada 
(Akada, 2004) was modified and used in this study: 
     27 μl of over night cultures were mixed with 3 μl 6x loading buffer. Then 25 μl of phenol-
chloroform mixture were added, and the sample was vortexed for 30 seconds; then 
centrifuged for 3 min at 13000 rpm. 15 μl of the upper water phase was loaded on an agarose 
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gel. The strongest bands on the gel were ribosomal RNA. Plasmids formed weaker bands 
above these. In addition to MW standards, reference plasmids were also added to the gel. 
 
2. General techniques for working with proteins 
 
     The purpose of the second part of this study was to work with recombinant protein: to 
express PINT protein in BL21(DE3)LysS  E.coli cells, purify and analyze it.  
 
2.1 Expression of recombinant protein in bacterial cells 
 
     In order to grow bacterial culture (BL21(DE3)LysS cells containing the expression 
plasmid pET-PINT) and later express recombinant PINT protein, the procedure described in 
Ni-NTA Spin Handbok by Qiagen was slightly modified and used in this study: 
     3 ml of LB medium containing 50 μg/ml ampicilin and 20 μg/ml chloramphenicol was 
inoculated with a fresh bacterial colony containing the expression plasmid and grown at 37 °C 
overnight. Next day 50 ml medium containing antibiotics was inoculated with 800 μl of 
overnight culture and grown at 37 °C with vigorous shaking until the OD550 reaches about 0.3. 
Later IPTG  (isopropyl β-D-1-thiogalactopyranoside, a inducer of the lac promoter) was 
added to the cells to a final concentration of 1 mM and the culture was grown at 37 °C* 
vigorously shaking over night**. After induction cells were harvested by centrifugation at 
4000x g for 15 min at RT and used in different assays or stored at -20 °C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* In some cases lower temperatures were used (16-30 °C) 
** In some cases the duration of this growth was shortened to 5-6 hours or increased up to 30        
hours, depending on the temperature 
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2.2 Recombinant protein purification 
 
     PINT protein expressed from pET-PINT vector has His6 tag on the N-terminal end. This 
tag was used for purification of PINT from cells lysates by using the Ni-NTA Spin Kit from 
Qiagen. Ni-NTA Spin Kit is based on unique and versatile metal chelate chromatography 
material, NTA ligand, packaged in spin column. NTA has a tetradentate chelating group that 
occupies for of six sites in the nickel coordination sphere. The metal is bound very tight and 
as the result the proteins are very strongly bound to the resign. The high affinity of the Ni-
NTA resins for His6-tagged proteins or peptides is due to both the specificity of the interaction 
between histidine residues and immobilized nickel ions, and to the strength with which these 
ions are held to the NTA resin. Ni-NTA silica material has been modified to provide a 
hydrophilic surface; non-specific hydrophobic interactions are kept to a minimum, while the 
silica support allows efficient microspin technology. 
 
     In this study protein purification under native and denaturing conditions were performed, 
since the interaction between Ni-NTA and the His6 tag of the recombinant protein does not 
depend on proteins tertiary structure. For detailed protocols see the manufacturer's handbook. 
     Protein purification under native conditions was performed exactly following the 
manufacturer's protocol in the handbook; except that in some cases, a French press was used 
instead of sonication. When using French press, cells were resuspended in 3 ml lysis buffer 
and lysozyme was not added to resuspended cells.  
 
     French press is a procedure that is used for disruption of cell walls by using high 
hydrostatic pressures without adding detergents (cells are sheared by forcing them through a 
narrow space) first described by Deckmann and coworkers (Deckmann et al., 1985). The 
pressure disrupts the cellular walls of a sample while leaving the cell nucleus undisturbed. 
This technique results in uniform and complete disruption. The two models of working cells 
give a choice of cell volume and working pressures. The 40K cell has a maximum working 
pressure of 40.000 psi and a cell capacity of 35 ml. The miniature cell used for work with 
small sample volumes holds from 1.4 to 3.7 ml and has a maximum working pressure of 
20.000 psi (in the present study the second one was used).  
 
     The protocol for purification under denaturing condition was slightly modified, mostly the 
lysis of cells. In this study cells were resuspended in 2 ml buffer B, incubated at room 
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temperature gently shaking for 3 hours, centrifuged at 13000x g for 20 min and supernatant 
was collected.  Further, the protocol from the handbook was followed. 
     In this study, in addition to Ni-NTA columns, His Gravi Trap (GE Healthcare) columns 
were also used for purification of recombinant proteins. For detailed protocol see the 
manufacturer's handbook.  
 
2.3 Inclusion bodies 
 
     It is often difficult to obtain soluble and active proteins from expression of eukaryotic 
proteins in prokaryotes. Often, the overexpression leads to the production of inclusion bodies, 
insoluble aggregates of misfolded protein. Formation of inclusion bodies protects proteins 
from proteolytic attack and toxic proteins can not inhibit cell growth when presented in 
inactive form. Inclusion bodies can be easily purified. However, the challenge is to convert 
the inactive and insoluble inclusion body protein aggregates into soluble, correctly folded and 
biologically active products (Clark, 1989) (kinetic competition between folding and 
aggregation always takes place in the cell (De Bernardez et al., 1998)).    
 
2.3.1 Purification of inclusion bodies 
 
     Cells from 250 ml culture were sedimented by centrifugation at 7000x g for 10 min, 
resuspended in 25 ml NaCl-Tris buffer pH 8.0 (for the composition of all buffers see 
Appendix 3), added lysozyme to a final concentration of 0.3 mg/ml and frozen at -20 °C. The 
cell membranes were disrupted by thawing the frozen cell suspension at 30-50 °C. After 
dilution with 25 ml NaCl-Tris buffer, and addition of MgCl2 and DNaseI (to the final 
concentration of 5 mM and 7 μg/ml, respectively), the suspension was stirred with a glass rod 
and drawn through an 18G syringe until the viscosity disappeared. The inclusion bodies were 
sedimented at 11000x g for 30 min at 4 °C, and washed twice with 600 ml NaCl-Tris buffer 
containing 1% Triton X-100 by magnetic stirring for 1 hour. The final pellet was resuspended 
in 25 ml 10mM NaCl-Tris buffer with 1 mM EDTA pH 8.0 and stored at -20 °C.  
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2.3.2 Solubilisation and refolding of inclusion bodies 
 
     In the present study a few different protocols for solubilisation of purified inclusion bodies 
and for refolding of recombinant protein were used (for the composition of all buffers see 
Appendix 3). 
 
     Protocol 1: inclusion bodies from 10 ml suspension (check 2.3.1 Purification of inclusion 
bodies) were pelleted at 18000x g for 15 min, dissolved in 30 ml refolding buffer containing 
6-8 M guanidine hydrochloride or urea by vortexing, and stirred over night at 4 °C*. Then the 
protein solution was filtered through a 0.2 μm filter before loading on Ni-NTA (Qiagen) or 
His Gravi Trap (GE Healthcare) column equilibrated with refolding buffer at 4 °C*. Buffer 
change from refolding to phosphate buffer was performed by washing column with 2 ml of 
refolding/phosphate buffers mixed in different ratio (starting from, refolding buffer: 
phosphate buffer 5:0, and finishing with: refolding buffer: phosphate buffer 0:5). After 
washing the column with 10 ml phosphate buffer, protein was eluted in phosphate buffer 
containing 300-500 mM imidazole.  
 
* in some cases room temperature was used.  
 
     Protocol 2:  this method is similar to one described in protocol one, just after dissolving of 
inclusion bodies in 30 ml buffer containing 6 M guanidine hydrochloride, suspension was 
stirred for 1 hour at RT before loading the protein solution on His Gravi Trap column (GE 
Healthcare); column was washed with 10 ml washing buffer containing 6 M urea and proteins 
were refolded by slowly washing the column with buffers containing different urea 
concentrations (from 6 M urea to 0 M, using 10 ml of buffer at the time). Protein was eluted 
in buffer without urea, containing 300 mM imidazole.      
 
     Protocol 3: dilution of the solubilised protein directly into renaturation buffer is the most 
commonly used method, however, the protein concentration has to be carefully controlled to 
prevent aggregation. In this study inclusion bodies were dissolved in 30 ml refolding buffer 
(protocol 1) and diluted 10x with buffer containing no detergent, but 10% glycerol at 4 °C or 
room temperature. Mixture was stirred slowly for 3 hours at 4 °C or RT, centrifuged at 
24000x g for 15 min at 4 °C to get rid of impurities, filtrated through 0.2 μm filter and loaded 
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on His Gravi Trap column (GE Healthcare) equilibrated with 10 ml dilution buffer. Protein 
was eluted with buffer containing 300 mM imidazole. 
 
     Protocol 4: method is similar to one described in protocol 3, just refolding buffer 
containing 8 M urea was used for solubilisation of washed inclusion bodies and then slowly 
diluted 10 times with buffer containing no urea.  
 
2.4 Polyacrylamide gel electrophoresis (PAGE) 
 
     Polyacrylamide is a polymer formed from acrylamide subunits that is readily cross-linked. 
Gel electrophoresis of proteins is usually done in an SDS (sodium dodecyl sulphate) 
polyacrylamide gel (for DNA, polyacrylamide is used for separating fragments of less than 
about 500 bp). SDS is an anionic detergent which denatures secondary and non-disulphide-
linked tertiary protein structures and applies a negative charge to each protein in proportion to 
its mass, making the protein mass the main factor that influences migration during 
electrophoresis.  The pore size of the gel may be varied to produce different molecular effects 
for separating proteins of different sizes. In this way, the percentage of polyacrylmide can be 
controlled in a given gel. By controlling the percentage (from 3% to 30%), precise pore sizes 
can be obtained, usually from 5 to 2.000 kDa. This is the ideal range for gene sequencing, 
protein, polypeptide, and enzyme analysis. The proteins move into the gel when an electric 
field is applied. The gel minimizes convection currents caused by small temperature 
gradients, and it minimizes protein movements other than those induced by the electric field. 
After electrophoresis proteins can be visualized by treating the gel with different stains. 
 
     In this study Criterion XT Precast Gels from BioRad were used (10-12% Bis-Tris). 
Electrophoresis was runned at 200 V for about 20-60 min, using XT MES or MOPS as 
running buffer. 
     Protein containing pellet was resuspended in 1x XT Sample buffer; supernatant with 
proteins were added 2x XT Sample buffer. Sample buffer contained MgCl2 (to lower the 
viscosity of the sample) and reducing agent, which reduce disulphide linkage. All protein 
samples and MW standards were boiled at 100 °C for 3 minutes before loading them in wells.  
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     The amount of each sample that was applies to the gel was calculated by using the 
equation: 
                                    amount of sample, μl  =  (X * 0.03)/ OD550 
                                    
where X is the amount of sample buffer used for resuspension of the pellet (μl); 0.03 is a 
constant, and OD550 is the optical density of the cell culture at 550 nm.  
 
2.5 Staining of polyacrylamide gels 
 
     Proteins separated by electrophoresis were visualized by treating the gel with 2 different 
stains: Coomasie Brilliant Blue (CBB) and Silver (for the composition of all buffers see 
Appendix 3).  
 
     CBB, an aminotriarylmethane dye, forms strong, but not covalent complexes with protein, 
most probably by a combination of van der Waals forces and electrostatic interactions with 
NH3+. This stain binds to the proteins but not to the gel itself. Each band on the gel represents 
a different protein (or a protein subunit). After electrophoresis, the gels were transferred to a 
bath with the staining solution and incubated at room temperature, gently shaking for 30 min. 
Then the staining solution was exchanged with destaining solution and the gel was incubated 
at room temperature for 24 hours. 
     Silver staining: there are two major classes of silver reagents used to stain proteins in 
PAGE gels: ammonial silver solutions and those that use silver nitrate (in this study the 
second one was used). The process relies on differential reduction of silver ions that are 
bound to the side chains of amino acids. This staining method is about 100-1000 fold more 
sensitive than staining with CBB. There are several different protocols for silver staining of 
the gels. The one used in this study is: 
     The gel was kept gently shaking in solution A for 2 hours, RT (solution was changed into 
fresh one each 30 min.). After that solution B was added to the gel for 45 min, RT. Later gel 
was washed with water for 1 hour (changing water every 10 min.). Solution C was added and 
gel was incubated for 1.5 hours at RT. After that solution D was added to the gel and gel was 
observed all the time. When protein bands became bright enough solution D was changed into 
solution E for 30 min. Later gel can be stored in the water up to 6 months.   
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3. General techniques for working with mammalian cells 
 
     The purpose of the last part of this study was to express PINT protein in mammalian cells. 
When expressed with a tag, different assays can be performed in order to characterize that 
protein, study its cellular localization, binding partners and so on.  
 
     In this study the neuroblastoma cell lines N2a (murine) and SH-SY5Y (human) and stable 
clones such as N2a-DsRed-Ex, N2a-PrP-EGFP, SH-DsRed-Ex were used. N2a cells were 
grown in minimum essential medium (MEM) added 10% foetal bovine serum (FBS), non-
essential amino-acids, 1% penicillin/streptomycin, 1% glutamine and 1% pyruvate. SH-SY5Y 
were grown in Dulbecco's modified Eagle's medium (DMEM) with addition of 1% glutamine, 
10% FBS and 1% penicillin/streptomycin. All cells were grown at 37ºC with 5% CO2 and 
saturated humidity.  
 
3.1 Transfection 
 
     Transfection is the introduction of foreign DNA into eukaryotic cells, such as animal cells. 
Transfection typically involves opening transient "holes" or gates in cell's plasma membrane 
to allow the entry of extracellular molecules, typically supercoiled plasmid DNA. 
 
     Cells were washed 1x with room tempered PBS and trypsinated until almost all of the cells 
became lose from the flask; suitable amount of the cells (depending on the assay) was 
transferred to a new plate and let grow over night. Introduction of foreign DNA into a cell 
was performed by liposomes, i.e. small, membrane-bounded bodies, which fuse with the cell 
membrane, releasing the DNA into the cell. N2a and SH-SY5Y cells were transfected with 
lipofectamine and Plus reagents (Invitrogen) according to the manufacturer's instructions in 
Opti-MEM medium. Usually, transient transfected cells were harvested 24 hours after 
transfection (see 3.3 Western blot analysis).  
 
     Stably transfected cells (SH-SY5Y) were selected with G-418-sulphate at a concentration 
of 0. 5 mg/ml. Several colonies were initially selected from this cell line. After screening for 
fluorescence intensity (Olympus IX81 fluorescence microscope) and PINT signals on 
Western blots, one clone was selected for further studies. 
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     Some stable clones were freezed and stored in nitrogen tanks. Before freezing cells were 
centrifuged at 1200 rpm for 5 min, resuspended in 3 ml medium with 10% DMSO, freezed 
down first at -80 °C over night and later transferred into nitrogen tank.    
 
3.2 Antibodies 
 
     Monoclonal (Mab) mouse-anti-His, C-terminal anti-His, N-terminal P4 and polyclonal 
rabbit anti-RFP were used in this study as primary antibodies. In Western blots, primary 
antibodies were used in concentrations of    0.05-0.2 μg/ml. For immunoprecipitation 1- 2 μg 
of antibodies were used. 
     Secondary antibodies, goat-anti-rabbit, goat-anti-mouse and anti-mouse true blot 
conjugated with horseradish peroxidase (HRP), goat-anti-mouse, conjugated with alkaline 
phosphatase (ALP) were used in 0.005-0.3 μg/ml concentrations. For detection enhanced 
chemiluminescence (HRP) or fluorescence (ALP) were used.   
 
3.3 Western blot analysis 
 
     Cells were harvested 24 hours after transfection. Before the lysis, cells were washed twice 
with ice cold PBS and scraped in RIPA buffer (all buffers are listed in Appendix 3) (N2a and 
SH-SY5Y transfected and untrasfected cells) or IP-lysis buffer (N2a-PrP-EGFP cells). For 
one million cells 200 μl buffer containing 15 μl protease inhibitor cocktail were used. Then 
cells were left to stay on ice for 30 min, and spinned down in a centrifuge for 5 min at 13000 
rpm; supernatant was collected.  
 
     60 μl supernatant was added 20 μl NuPAGE LDS Sample buffer, 8 μl NuPAGE Sample 
Reducing agent and mixture was boiled for 5 min before applying on the gel.  
     For Western blots, proteins were separated by SDS-gel electrophoresis (see 2.4 
Polyacrylamide gel electrophoresis) (at 200V for 1 hour; using MOPS as the running buffer; 
Criterion XT precast gel, 12% Bis-Tris (Biorad)) and electroblotted onto polyvinylidene 
difluoride membranes with a semi-dry blotter (BioRad); proteins were blotted for 45 min at 
25 V with Tris/CAPS transfer buffer as recommended by the supplier). To reduce unspecific 
binding of antibodies, membranes were blocked by incubation with 5% (w/v) fat-free dried 
milk in TBS-T for 1 hour at room temperature. Incubation with primary antibodies was 
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performed in TBS-T and 1% (w/v) fat-free dried milk at 4 °C over night, while with 
secondary antibodies for 1 hour at room temperature. After both incubations membranes were 
washed 4x 15 min with TBS-T. Visualization of bands were achieved with enhanced 
chemiliuminescence  (ECL Plus, Amersham Biosciences), captured by ECL Hyperfilm 
(Amersham Biosciences) or by fluorescence scanning with a variable mode imager (Typhoon 
9200, Amersham Biosciences), when secondary antibodies labelled with ALP.  
 
     It is possible to strip the membrane, completely remove primary and secondary antibodies 
and reprobe the same membrane several times. In order to do that, membrane was added 
striping buffer and incubated at 60 °C 2x 15 min; washed 2x 10 min with large amounts of 
TBS-T at RT and blocked with 5% fat-free dried milk in TBS for 1 hour at RT; later 
membrane was incubated again with primary and secondary antibodies.    
 
3.4 Immunoprecipitation 
 
     Immunoprecipitation (IP) is a procedure by which peptides or proteins that react 
specifically with an antibody are removed from solution and examined for quantity or 
physical characteristics. Antibody-antigen complexes are removed from solution by addition 
of an insoluble form of an antibody binding protein such as Protein A, Protein G or second 
antibody. The procedure can be divided into several stages: sample preparation; preclearing; 
antibody incubation/formation of antibody-antigen complexes and precipitation. The principle 
of immunoprecipitation is presented in Figure 6.  
     Co-immunoprecipitation (Co-IP) is a popular technique for protein interaction discovery. 
Co-IP is conducted in essentially the same manner as an IP. However, in a co-IP the 
interacting protein is bound to the target antigen, which becomes bound by the antibody that 
becomes captured on the Protein A or G gel support. The principle of Co-IP is presented in 
Figure 7.  
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Figure 6: Principle of IP 
(Taken from http://www.piercenet.com/Products/Browse.cfm?fldID=9C471132-0F72-4F39-8DF0-
455FB515718F) 
 
 
 
Figure 7: Principle of Co-IP  
(Taken from http://www.piercenet.com/Products/Browse.cfm?fldID=9C471132-0F72-4F39-8DF0-
455FB515718F) 
 
 
     In this study both IP and Co-IP were used (all buffers are listed in Appendix 3).  
     While working with anti-His (C-term) antibody, the IP procedure recommended by the 
manufacturer (Invitrogen) was followed. For a detailed protocol see the manufacturer's 
handbook. 
     For other antibodies slightly modified IP protocol was used. 150 μl of cell lysate (se 3.3 
Western Blot analysis) was precleared for 30 minutes at 4 °C with 20 μl of washed (3x for 1 
min with IP-wash solution and 3x for 1 min with IP-wash solution with 1% BSA) protein A 
or G beads. Beads were removed by centrifugation at 13000 rpm for 1 min. 1-2 μg of primary 
antibody were added to the lysate and rolled at 4 °C over night. At the same time a new 
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portion of beads were washed 3x for 1 min with IP-wash solution, added 1ml IP-wash 
solution with 1% BSA and rolled at 4 °C over night. Next day 20 μl of washed beads were 
added to lysate and rolled for 3 hours at 4 °C. Beads were sedimented at 13000 rpm for 1 min, 
and washed 3x with buffer containing BSA and 3x with buffer without BSA; beads were 
added sample buffer with reducing agent, boiled for 5 min and sedimented one more time, to 
avoid application of beads on the gel.  
     To perform Co-IP, 24 hours after transient transfection, N2a-PrP-EGFP cells were gently 
lysed using IP-lysis buffer; then lysates were added anti-RFP (directed against DsRed-Ex) or 
P4 (directed against PrP) and incubated over night at 4 ºC. Next day A or G beads were added 
to lysates containing anti-RFP or P4 antibodies, respectively, and incubated for additional 3 
hours at 4 ºC. Samples were added sample buffer containing reducing agent, boiled for 5 min 
and applied on the gel. For detection of prion protein, P4 (1:10.000) and mouse true blot HRP 
(1:1.000) were used as primary and secondary antibodies, respectively. In order to detect 
PINT-DsRed-Ex, anti-RFP (1:16.000) and goat anti-rabbit HRP (1:15.000) were used.  
 
3.5 Other assays performed in this study 
 
     In this study a few other assays were used in order to study cellular localization, signal 
sequences and other properties of PINT protein. 
 
3.5.1 Leptomycin B studies of nuclear export 
 
     Small proteins and other molecules constantly move into and out of the cell nuclei. A 
number of such proteins have nuclear import and export leucine rich sequences. Leptomycin 
B is an unsatured, branched-chain fatty acid, an antibiotic with anti-fungal and anti-tumour 
activity (Hamamoto et al., 1983; Hamamoto et al., 1985), and a specific inhibitor of nuclear 
export signal. The suggested inhibition mechanism involves the direct binding of Leptomycin 
B to CRM1 (exportin 1), which blocks binding of CRM1 to proteins containing the nuclear 
export signal (Henderson et al., 2000; Nishi et al., 1994), via interaction with a cysteine 
residue in the CRM1 central conserved region (Kudo et al., 1999).    
 
     Before the treatment with leptomycin B, cells were synchronized, in order to ensure that 
cells progress through the cell cycle in a synchronous manner. To synchronize cells, several 
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methods are used. Commonly, cells are induced to quiescence by serum starvation before 
releasing them from this state, or cells are treated with chemical inhibitors which arrest cells 
in distinct phases of the cycle. 
     In this study cells were grown in medium containing 0.5% FBS (normal medium contains 
10% FBS) for 2-3 days. This deprives the cells of the nutrients required to proliferate and 
forces the cells into quiescence, namely G0-phase. The cells were released from quiescence by 
adding back serum to the medium. 
     Cells were added leptomycin B to the end concentration of 20 mM in Opti-MEM or 
DMEM with 10% serum and incubated at 37 °C. After 2.5 hours cells were fixed with 
formaldehyde and mounted with DacoCytomation fluorescent mounting medium and 
screened for fluorescence intensity.  
 
3.5.2 PNGase F treatment 
 
     Glycosylation is one of many post-translational modifications of proteins. Two types of 
glycosylation exist: O-linked glycosylation to the hydroxy oxygen of serine and threonine 
side chains and N-linked glycans, which are attached to the protein backbone via an amide 
bond to an asparagine residue in an Asn-Xaa-Ser/Thr motif, where X can be any amino acid, 
except Pro (Maley et al., 1989). The most frequent enzyme used for deglycosylation of 
glycoproteins is N-glycosidase F (PNGase F). This enzyme hydrolyzes nearly all types of N-
glycans chains from glycoproteins. 
     For enzymatic deglycosylation samples were treated with PNGase F, for 1 hour at 37 °C, 
as recommended by the manufacturer. For detailed protocol see the manufacturer's handbook.   
 
3.5.3 Fluorescence protease protection (FPP) assay 
 
     FPP is a fluorescence based technique for investigating the topology of proteins and for 
localizing protein subpopulations within the complex environment of the living cell. The 
assay provides fluorescence readout in response to enzyme (trypsin or proteinase K) induced 
destruction of fluorescent tag attached to a protein of interest before and after plasma 
membrane permeabilization. This technique was published by Lorenz and colleagues (Lorenz 
et al., 2006). By this assay it is possible to determine whether a protein is membrane 
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associated, cytoplasmic or luminal and which part of a membrane protein faces the lumen (or 
cell exterior) and cytoplasm. 
     Treatment with trypsin of nonpermeabilized cells should readily extinguish fluorescence 
associated with molecule facing the cell exterior, but have no effect on fluorescence 
associated with molecule facing the cell interior. In order to permeabilize cell walls, digitonin 
was added to the cells. When added to the cells, digitonin, a small toxin, intercalates into 
cholesterol-rich membranes by forming a complex with hydroxysterols, causing the plasma 
membrane to become perforated (Plutner et al., 2002). Small molecules can then diffuse out 
of the cell from cytoplasm and nucleus, while, small external molecules such as trypsin can 
diffuse into the cell. Trypsin is a serine proteases found in the digestive system, where it 
breaks down proteins by cleaving peptide bonds in proteins. When in the cell, trypsin 
extinguishes fluorescence from bound molecules facing the cytosol, which can not diffuse out 
of the cell. However, molecules localized in different organelles such as Golgi, ER, 
mitochondria, peroxisomes and others, are protected from trypsin and fluorescent signal is not 
affected.  
     The similar results can be achieved by using proteinase K instead of trypsin, which is also 
a serine protease that cleaves peptide bonds at the carboxylic sides of aliphatic, aromatic or 
hydrophobic amino acids. 
 
     In this study digitonin concentration of 40 mM was sufficient to release DsRed-Ex from 
the cytosol in N2a and SH-SY5Y cell lines; trypsin was applied directly to the cells at 
concentration of 4 mM, proteinase K was used at final concentration of 50 µg/ml.  
     Cells were grown in glass chamber slide (Lab-Tec, NUNC), and transfected as previous 
described. After 24 hours cells were washed with room temperatured KHM buffer and added 
digitonin, later added KHM buffer with trypsin or proteinase K, and occurred changes in 
fluorescent signal was captured with microscope.  
 
     Biochemical protease protection assay: for this assay the protocol published by Lorenz and 
colleagues (Lorenz et al., 2006) was slightly modified and used in the present study. 
     Transiently transfected N2a cells 24 hours after transfection were washed 1x with PBS, 
trypsinated, washed 1x with MEM with 10% serum to stop trypsin action, and then 1x with 
KHM buffer (Appendix 3). Washes were performed using 5 min centrifugations at 4 °C, 500x 
g. 25% of washed cells were added SDS-buffer and boiled at 100 °C for 5 min (fraction: 
homogenate of whole cells). Rest of the cells were added digitonin to the end concentration of 
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40 μM, incubated on ice for 10 min and divided into three tubes. One tube was centrifuged at 
4 °C for 30 min, 50000x g (supernatant-cytosol fraction; pellet-membrane fraction). Cells in 
the second tube were added trypsin or proteinase K to a final concentration of 4 mM and 50 
µg/ml, respectively; the third tube was added trypsin/proteinase K to a final concentration of 4 
mM/50 µg/ml and 1% (vol/vol) triton X-100. Both tubes were incubated on ice for 30 min 
and then centrifuged at 4 °C for 30 min, 50000x g. Pellet was carefully washed with KHM 
buffer and treated with benzonase for the removal of nucleic acids from protein samples 
(pellet was added benzonase buffer (Appendix 3) and boiled for 5 min, later 1µl of benzonase 
(344 units) was added to each sample and induced at 37 ºC for 1 hour). Samples were added 
sample buffer, boiled for 5 min and loaded on a gel.  
 
4. Fluorescence microscopy 
 
     Fluorescence microscopy is used to detect structures, molecules or proteins within the cell. 
Fluorescent molecules absorb light at one wavelength and emit light at another, longer 
wavelength. When fluorescent molecules absorb a specific absorption wavelength for an 
electron in a given orbital, the electron rises to a higher energy level (the excited) state. 
Electrons in this state are unstable and will return to the ground state, releasing energy in the 
form of light and heat. This emission of energy is fluorescence. Because some energy is lost 
as heat, the emitted light contains less energy and therefore is a longer wavelength than the 
absorbed (or excitation) light.    
     In fluorescence microscopy, a cell is stained with a dye and the dye is illuminated with 
filtered light at the absorbing wavelength; the light emitted from the dye is viewed through a 
filter that allows only the emitted wavelength to be seen. The dye glows brightly against a 
dark background because only the emitted wavelength is allowed to reach the eyepieces or 
camera port of the microscope.  Most microscopes are designed using epi-illumination. In epi-
illumination excitation, light goes through the objective lens and illuminates the object. Light 
emitted from the specimen is collected by the same objective lens (Figure 8). 
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Figure 8: The optical system of an epi-fluorescence upright microscope (taken from 
http://dept.kent.edu/projects/cell/fluoro.htm) 
 
 
 
     In this study Olympus IX81 fluorescence microscope was used for imaging and capturing 
of signals.  
     PINT protein was fused with red fluorescent protein, while one of stable N2a cell lines, 
N2a-PrP-EGFP, had enhanced green fluorescent protein (EGFP) fused to PrP (emission and 
excitation spectra for EGFP and DsRed are presented in Figure 9) (Billinton et al., 2001).  
 
 
     
 
 
Figure 9: Excitation and emission spectra for EGPR and DsRed (Billinton et al., 2001) 
 
 - 53 -
III. Results 
 
1. Cloning 
 
1.1 pDsRed-Express-PINT construct 
 
     For production of the pDsRed-Express-PINT construct, PCR was runned using PINTRedR 
and PINTRedF primers (Table 3) and pGEM-T-Easy-PINT 1B clone as template DNA to 
amplify PINT fragment. Later this PINT fragment and pDsRed-Express-N1 vector were cut 
with the restriction enzymes BglII and BamHI in BamHI buffer; after ligation with T4 DNA 
ligase, a new opened reading frame was formed (Appendix 1) comprising whole PINT protein 
connected to N-terminal of DsRed-Express (variant of red fluorescent protein). Competent 
DH5α cells were added aliquots ligation reaction mix, streaked out on preheated LB plates 
containing 50 μg/ml canamycin and incubated at 37 °C over night. Next day a few of the 
colonies were picked, inoculated in 2 ml LB medium containing canamycin and grown over 
night with vigorous shaking at 37 °C. Plasmid DNA was isolated with Plus Sv Minipreps 
DNA Purification System from Promega.  
     Restriction fragment analysis was used to verify a successful introduction of insert into 
vector (Figure 10). Plasmid cut with BglII and BamHI (lane 1) showed two DNA fragments 
of about 5000 and 800 bp, (vector and PINT fragment, respectively), because PINT fragment 
has restriction sites of these enzymes on the both sides. Plasmid containing PINT insert and 
empty vector were also analysed with BsaHI restriction enzyme in NE Buffer 4 (Figure 10). 
This analysis also indicated that plasmid contains the PINT fragment. BsaHI enzyme has a 
few restriction sites in pDsRed-Express-N1 vector, and one in PINT fragment. Because of 
that, restriction analysis of pDsRed-Express-PINT (lane 2) showed one additional fragment 
on the agarose gel if compared to analysis of empty vector (lane 3).  
     Before starting other experiments with this construct, pDsRed-Express-PINT was 
sequenced to confirm correct amplification and cloning using DsRedR and DsRedF primers 
(Table 3). Later this construct was used for expression of PINT-DsRed-Express protein 
(PINT-DsRed-Ex) in mammalian cells.  
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Figure 10: Restriction analysis of pDsRed-Express-PINT: 1) pDsRed-Express-PINT cut with 
BglII and BamHI; 2) pDsRed-Express-PINT cut with BsaHI; 3) pDsRed-Express-N1 vector 
cut with BsaHI; 1% agarose gel.  
 
1.2 pZeoSV-PINT construct 
 
     To make pZeoSV-PINT construct, PCR was runned using PINT-Z-R and PINT-Z-F 
primers (Table 3) and pGEM-T-Easy-PINT 1B clone as template DNA to amplify PINT 
fragment. Amplified fragment and pZeoSV vector were cut with two restriction enzymes, 
AgeI and MluI, in R-buffer containing BSA; after ligation a new open reading frame was 
formed containing the whole PINT ORF with C-terminal His6-tag (Appendix 1).  
     Transformed DH5α E.coli colonies were grown on LB plates containing 50 µg/ml zeocin 
over night. Next day a few of the colonies were picked, inoculated in 2 ml LB medium 
containing zeocin and grown over night with vigorous shaking at 37 °C. Plasmid DNA was 
isolated with Plus Sv Minipreps DNA Purification System from Promega.  
     Restriction analysis was performed to confirm that the insert was successfully introduced 
into the vector (Figure 11). After cutting plasmid with AgeI and MluI, two DNA fragments 
were formed (lane 1), since PINT-His6 fragment contains restriction sites of both enzymes. 
The larger fragment (≈ 3500 bp) matched pZeoSv vector, while smaller fragment (≈ 850 bp) 
matched PINT-His6.  
     Prior to further studies of this construct, pZeoSV-PINT was sequenced to confirm correct 
amplification and cloning using SP6 and T3 primers (Table 3). Later this construct was used 
for the expression of PINT-His6 protein in mammalian cells.  
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Figure 11: Restriction analysis of pZeoSv-PINT construct: 1) plasmid cut with AgeI and 
MluI; 2) parallel experiment using different E.coli colony; 1% agarose gel.  
       
 1.3 pET-PINT construct 
 
     To construct pET-PINT, primers PINTlongF and PINT-pETcorrR (Table 3) and pET-
PINT-16b as template DNA were used to run PCR. After amplification, PINT fragment and 
pET16B vector were cut with two restriction enzymes, NdeI and BamHI, in R-buffer 
containing BSA; after ligation a new plasmid, coding for PINT with N-terminal His6-tag, was 
formed (Appendix 1). DH5α E.coli were streaked out LB-plates containing 50 µg/ml 
ampilicin and grown over night. A few colonies were inoculated in 2 ml LB medium, grown 
over night and DNA was purified with Plus Sv Minipreps DNA Purification System from 
Promega.  
     Restriction analysis with NdeI and BamHI enzymes was performed (Figure 12), because 
PINT fragment has restriction sites of both enzymes. After this cut two DNA fragments were 
seen on the agarose gel: one, that matched pET16B vector, and second, slightly smaller than 
850 bp, matching PINT fragment. 
     Prior to further studies of this construct, pET-PINT was sequenced to confirm correct 
amplification and cloning using T7R and T7R primers (Table 3). Later this construct was used 
for the expression of His6-PINT protein in bacterial cells. 
 
 
 
Figure 12: Restriction analysis of pET- PINT: 1) pET-PINT cut with NdeI and BamHI; 2) 
parallel experiment with different E. coli colony; 1% agarose gel.    
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2. Results of PINT protein expression in bacterial cells 
 
2.1 Protein expression at 37 °C in E.coli 
 
     The pET system is a powerful system for cloning and expression of recombinant proteins 
in bacterial cells. In order to express recombinant protein, target genes have to be induced 
with IPTG; after induction it takes just a few hours and desired protein can comprise more 
than 50% of the total cell proteins. In the present study pET-PINT construct was used for 
expression and purification of His6-PINT protein in E.coli BL21 cells. His6-PINT is about 35 
kDa protein.  
     First, cell growth and protein purification were performed as recommended by the 
manufacturer by using Ni-NTA Spin kit from Qiagen. To 50 ml of NZCYM medium 
containing ampicilin and Chl were added 800 µl cell suspension (E.coli BL21 cells containing 
pET-PINT plasmid); cells were grown until optical density of suspension reached 0.3 at 550 
nm, induced with IPTG and grown for about 5 hours with vigorous shaking at 37 °C.  Some 
samples were taken before and after induction and analysed by SDS-PAGE (Figure 13). His6-
PINT was observed on the gel already after 1 hour of induction (lane 3); after 5 hours, 35 kDa 
band was very strong (lane 6), indicating high concentration of His6-PINT protein.  
 
 
 
Figure 13: Induction of cell suspension with IPTG: 1) sample before adding IPTG; 2-6) 
samples after 0.5, 1, 2, 3 and 5 hours after induction, respectively; 10%  polyacrylamide gel 
stained with CBB.  
 
 
     After five hour induction cells were harvested by centrifugation and later used in 
purification assays.  
     For purification under native conditions, cells were added lysis buffer and lysozyme, 
incubated on ice for 30 min; cell walls were disrupted by sonication or French press, and after 
0.5 hour centrifugation at 10000x g the collected supernatant was loaded on a Ni-NTA spin 
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column. The column was washed twice and PINT was eluted in elution buffer. Samples after 
each step were analysed by SDS-PAGE (Figure 14).  
     Purification under denaturing conditions ensures that all His6-tagged proteins in the cell are 
solubilised and that His6 tag is fully exposed, which leads to more efficient purification. After 
lysis with strong denaturants, cells were centrifuged for 0.5 hour at 13000x g and the collected 
supernatant was loaded on a Ni-NTA spin column. His6-PINT was eluted in elution buffer 
after two washes. Samples of each step were analysed by SDS-PAGE (Figure 14). 
     His6-PINT was not eluted neither by native nor denaturing conditions (lanes 5-6 and 11-12, 
respectively), no bands were seen at the expected 35 kDa size; PINT protein was not seen in 
cell lysates either (lanes 1 and 7) (just very small amount of protein at size of 35 kDa were 
seen on the gel in cell lysates when purification was performed under denaturing conditions 
(lane 7), indicating that denaturing conditions as well as native ones are too mild for 
purification of His6-PINT). This result showed that His6-PINT protein is not soluble when 
expressed in E. coli at 37 °C, probably due to formation of inclusion bodies  
 
     
   
Figure 14: His6-PINT purification: native conditions: 1) cell lysate; 2) flow-through; 3-4) 
washes; 5-6)eluates; denaturing conditions: 7) cell lysate; 8) flow-through; 9-10) washes; 11-
12) eluates; 10% polyacrylamide gel stained with CBB.  
 
2.2 PINT expression and purification under different conditions 
 
     Inclusion bodies are a common problem when expressing recombinant proteins in 
prokaryotes. It is often difficult to obtain soluble and active proteins. Often, overexpression of 
recombinant protein leads to the production of inclusion bodies- insoluble aggregates of 
misfolded protein. 
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     In order to avoid the formation of inclusion bodies, different growth conditions of bacterial 
cell culture were applied in the present study.  
     Bacterial culture was grown at 16-25 °C temperature until optimal density of cell 
suspension at 550 nm reached about 0.3, and then was induced with IPTG at the final 
concentration of 1mM. Because of lower temperature induction time was increased up to 35 
hours (16 °C). Afterwards, cells were centrifuged and purification at native and denaturing 
conditions was performed as described above. No effect of lower temperature was observed; 
even when expressed at 16 °C, His6-PINT remained in its insoluble form (data not shown).     
      
2.3 Inclusion bodies 
 
     After all unsuccessful attempts to avoid formation of inclusion bodies, the best conditions 
to wash and solubilise inclusion bodies, to refold and elute His6-PINT protein has were 
studied. 
      E.coli BL21 cells were grown at 37 °C as described in 2.1 chapter in Materials and 
Methods.  After 4 hour induction with IPTG cells were sedimented, and His6-PINT inclusion 
bodies were washed following protocol described in 2.3.1 chapter of Materials and Methods. 
Sample containing washed inclusion bodies was analysed by SDS-PAGE (Figure 15). After 
the washes PINT inclusion bodies were quite pure, just minor impurities were seen on the gel.  
       
  
 
 Figure 15: Washed inclusion bodies; 10% polyacrylamide gel stained with CBB.  
 
 
     From this stage on, different methods were tried out to solubilise and refold PINT protein, 
because in order to obtain soluble and active protein, the protein has to be refolded after 
solubilisation of inclusion bodies.  
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2.4 Refolding of PINT protein on the column 
 
     Inclusion bodies can be solubilised in buffers containing high concentrations of strong 
detergents. In this study buffers containing 6-8 M guanidine hydrochloride or urea were used 
(for composition of all buffers used to refold PINT protein on the column see Appendix 3; for 
detailed protocols see 2.3.2 chapter in Materials and Methods). 
     Washed inclusion bodies were dissolved in refolding buffer containing 6 M guanidine 
hydrochloride by sonication and vortexing, and were stirred over night at 4 °C. Solubilised 
protein was filtered through 0.2 μm filter before loading onto His Gravi Trap column. Buffer 
change from refolding to phosphate buffer was performed by slowly washing the column with 
refolding/phosphate buffers in different ratio. Protein was eluted in phosphate buffer 
containing 300 mM imidazole (Figure 16 A). It was clear that at 4 °C solubilisation was 
unsuccessful; protein was lost in the filter (lane 3) and no protein was eluted (Figure 16A, 
lanes 10 and 11). 
     To solve this problem, solubilisation and refolding of His6-PINT again was performed in 
guanidine hydrochloride buffer, but this time at room temperature (Figure 16 B). Still, PINT 
was not eluted from the column (lane 11), but inclusion bodies were solubilised (after 
filtration, supernatant gave a strong band of about 35 kDa (Figure 16B, lane 4)) and PINT 
protein was bound to the column, because no protein was detected in flow-through (Figure 
16B, lane 5). 
 
 
 
Figure 16: A) inclusion bodies solubilised at 4 °C in guanidine hydrochloride buffer:  
1) sample after 4 hour induction with IPTG; 2) inclusion bodies in refolding buffer; 3) 
supernatant after filtration; 4) flow-through; 5-8) buffer change (refolding: phosphate buffer- 
4:1, 3:2: 2:3 and 1:4 ratio, respectively); 9) wash; 10-11) eluates; B) inclusion bodies 
solubilised at room temperature in guanidine hydrochloride buffer: 1) washed inclusion 
bodies; 2) inclusion bodies in refolding buffer; 3) supernatant after centrifugation; 4) 
supernatant after filtration; 5) flow-through; 6-9) buffer change (refolding: phosphate buffer- 
4:1, 3:2: 2:3 and 1:4 ratio, respectively); 10) wash; 11) eluate.   
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     Afterwards another strong detergent, urea, was also used for solubilisation of inclusion 
bodies and refolding of protein at 4 °C or RT. All attempts were unsuccessful. Inclusion 
bodies were not dissolved at all (4 °C) or protein was not eluted (RT) from the column (data 
not shown).  
     The same negative results were obtained in attempt to solubilise and refold His6-PINT 
protein combining two buffers containing both detergents. In order to do that, washed 
inclusion bodies were dissolved in buffer containing 6 M guanidine hydrochloride by 
vortexing, and suspension was stirred at RT for 1 hour. After loading suspension onto the His 
Gravi trap column, the column was slowly washed with buffer containing 6 M urea. PINT 
was refolded by very slowly washing column with buffers containing different urea 
concentrations (from 6 M urea to 0 M); but anyway, no His6-PINT protein was eluted in 
buffer containing 300 mM imidazole (Figure 17).  
 
 
 
Figure 17: Refolding of inclusion bodies by combining buffers containing guanidine 
hydrochloride and urea: 1) washed inclusion bodies; 2) eluate; 10% polyacrylamide gel 
stained with silver stain.  
 
2.5 Refolding of PINT by dilution 
 
      Dilution is one of the most popular methods for refolding of inactive proteins. In the 
present study a few different protocols were used (see 2.3.2 chapter in Materials and 
Methods). Washed inclusion bodies were solubilised in refolding buffer containing strong 
detergent, stirred over night at RT, very slowly diluted ten times with buffer containing no 
detergent (dilution was performed at 4 °C or RT) and stirred with magnet for 3 hours (4 °C or 
RT). Afterwards, mixture was centrifuged for 15 min, filtered through 0.2 µm filter and 
loaded onto the column. Protein was eluted in elution buffer containing 300 mM imidazole 
(Figure 18). Lanes 6-7 indicated that His6-PINT protein was not eluted from the column. 
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Figure 18: Refolding of PINT protein by dilution: 1) washed inclusion bodies; 2) inclusion 
bodies in refolding buffer; 3) supernatant after dilution; 4) supernatant after filtration; 5) flow- 
through; 6-7) eluates; 10% polyacrylamide gel stained with CBB.   
 
 
     It is possible that His6-PINT protein did not bind to the column at all (just because of high 
dilution no protein was detected in flow-through (Figure 18, lane 5)), or bound column so 
strong that was not eluted from the column. 
 
2.6 Second pET-PINT construct 
 
     All the experiments described in chapter 2 in Results were performed using pET-PINT 
construct coding for His6-PINT protein with twenty additional amino acids on its C-terminal 
end (if compared to the longest protein form in vivo; see Alternative splicing in Introduction). 
To check if this additional tail was influencing the solubility of PINT protein, a new construct 
with the correct C-terminal end was made (see 1.3 pET-PINT construct in the Results). 
Plasmid was amplified in DH5α E.coli cells; purified using Plus Sv Minipreps DNA 
Purification System from Promega, and then used for transformation of competent E.coli 
BL21 cells. Transformed cells were grown on NZCYM-plates containing ampicilin/Chl over 
night. Some colonies were picked, inoculated with 2ml NZCYM medium containing both 
antibiotics and grown over night at 37 °C with vigorous shaking.  Further purification under 
native conditions was performed exactly as described above. Samples after each step was 
analysed by SDS-PAGE (Figure 19).  
     Already after one hour induction with IPTG cells started to synthesize His6-PINT protein 
(lane 2); concentration of PINT was high after over night induction with IPTG (lane 5). After 
lysis and centrifugation both, supernatant and pellet were applied on a gel (lanes 6 and 7, 
respectively). Lane 7 indicated inclusion bodies of His6-PINT, because all protein remained in 
the pellet, no protein was seen in supernatant, and no bands were observed in eluates at the 
expected size (lanes 11-12). It seems that removal of the additional amino acid tail had no 
effect on the solubility of His6-PINT protein.  
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Figure 19: Purification of correct size His6-PINT protein under native conditions: 1) sample 
before induction with IPTG; 2-5) samples after 0.5, 1, 2 hours and over night induction, 
respectively; 6) supernatant after lysis and centrifugation; 7) pellet after lysis and 
centrifugation; 8) flow-through; 9-10) washes; 11-12) eluates; 10%polyacrylamide gel stained 
with CBB.   
          
3. PINT protein expression in mammalian cells 
 
3.1 Expression of PINT-His6 in mammalian cells 
 
     To study the localization of PINT protein in mammalian cells, pZeoSV-PINT construct, 
coding for PINT-His6 protein, was used. PINT-His6 is about 30 kDa protein. His6 tag is a 
small, not fluorescent tag, so success of transfection can not be confirmed by fluorescent 
microscope. 
     N2a cells were transiently transfected with pZeoSV-PINT. 24 hours after transfection, cells 
were lysed and analyzed in western blot. As a control, untransfected cells were used. Two 
different anti-His antibodies (Invitrogen and Amersham Bioscience) were used as primary 
antibodies (1:5000). Both goat-anti-mouse ALP- (1:5000) and goat-anti-mouse HRP- 
(1:20000) conjugated secondary antibodies were tested, and signals were captured by 
Thyfoon scanning and hyperfilm, respectively. Western blot analysis did not show any 
difference between untransfected control (Figure 20, lane 1) and transfected cells (Figure 20, 
lanes 2-3); no bands were seen at the size of about 30 kDa.  
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Figure 20: Western blot analysis of PINT-His6: 1) untransfected N2a cells; 2-3) N2a cells 
transiently transfected with pZeoSV-PINT; A) signal detected with anti-His (Invitrogen) and 
goat-anti-mouse HRP; B) signal detected with anti-His (Amersham Bioscience) and goat-anti-
mouse ALP; 12% polyacrylamide gel.  
 
 
     Immunoprecipitation with two different anti-His antibodies of PINT protein from lysates 
did not give positive results either (results not shown). 
 
     From this stage on, PINT fused with DsRed-Express protein (coded by pDsRed-Express-
PINT) was used for further studies, because of all unsuccessful attempts to detect PINT-His6 
protein in murine N2a cells by analyzing lysates directly or after immunoprecipitation in 
western blots.  
 
3.2 PINT protein cellular localization   
 
     To study cellular localization of PINT protein, two assays were used in the present study: 
transfection of N2a and SH-SY5Y cells with pDsRed-Express-PINT and fluorescence 
protease protection (FPP) assay.   
     First both cell lines were transiently transfected with pDsRed-Express-PINT, which codes 
for PINT-DsRed-Express (PINT-DsRed-Ex) protein, using lipofectamine and Plus reagents. 
Successful transformation was confirmed by fluorescence microscope 24 hours after 
transfection. A strong red signal was seen in both cell lines (Figure 21).     
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Figure 21: PINT-DsRed-Ex 24 hours after transfection, expressed in: A) N2a cells; B) SH-
SY5Y cells.  
 
 
     In order to compare the signal from the PINT-DsRed-Ex protein to DsRed-Ex alone, both 
cell lines were also transiently transfected with pDsRed-Ex (Figure 22). It was clearly seen 
that the localization of signal in the cells transfected with pDsRed-Ex (Figure 22 A and C) is 
quite different if compared to cells transfected with pDsRed-Express-PINT (Figure 22 B and 
D). DsRed-Ex is a small 28 kDa protein, which is localized mostly in cytoplasm and nucleus, 
and which gives an even signal all over the cell when red filter in fluorescent microscope is 
used. When cells were transfected with pDsRed-Express-PINT, the red signal, in most cases, 
was localized around the nucleus of the cell. In some cells the signal was also detected in 
nucleus in different patterns, and other cells had so strong and bright signal that it was 
impossible to decide the cellular localization.       
 
 
A B
C D
 
Figure 22: Transiently transfected cells (24 hours after transfection): A-B) N2a cells 
transfected with pDsRed-Express and pDsRed-Express-PINT, respectively; C-D) SH-SH5Y 
cells transfected with pDsRed-Express and pDsRed-Express-PINT, respectively. 
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     Western blot analysis of transfected cells confirmed that PINT-DsRed-Ex protein was 
expressed in the cells (Figure 23). Transiently transfected cells (N2a and SH-SY5Y) were 
harvested 24, 48 and 72 hours after transfection for detection of PINT-DsRed-Ex protein 
(about 50 kDa). Unfortunately, the anti-RFP antibody from Chemicon gave unspecific bands 
at the same size as PINT-DsRed-Ex protein in untransfected N2a and SH-SY5Y cells (Figure 
23, lanes e and h, respectively) making it difficult to confirm the presence of PINT protein in 
transfected cells. The unspecific bands disappeared when reducing agent was omitted from 
the samples (Figure 23, lanes D and H). PINT was synthesized in both cell lines 24, 48 and 72 
hours after transfection.  
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Figure 23: Western blot analysis of transiently transfected N2a and SH-SY5Y cells: samples 
added reducing agent: a-c) transfected N2a cells harvested after 24, 48 and 72 hours; d) 
untrasfected N2a cells; e-g) transfected SH-SY5Y cells harvested after 24, 48 and 72 hours; 
h) untrasfected SH-SY5Y cells; samples without reducing agent: A-C) transfected N2a cells 
harvested after 24, 48 and 72 hours; D) untrasfected N2a cells; E-G) transfected SH-SY5Y 
cells harvested after 24, 48 and 72 hours; H) untrasfected SH-SY5Y cells; 12% 
polyacrylamide gel, signal detected with anti-RFP (1:500) (Chemicon) and goat-anti-rabbit 
HRP (1:15000). 
 
 
     Fluorescence protease protection (FPP) assay was used to study the localization of PINT 
protein in detail. FPP provided fluorescence readout in response to trypsin or proteinase K 
induced destruction of DsRed-Ex attached to PINT protein before and after plasma 
membrane permeabilization.  
     N2a cells transiently transfected with pDsRed-Express-PINT were washed once with 
KHM buffer 24 hours after transfection (Figure 24II A), after removing washing buffer, 
trypsin at a final concentration of 4 mM was added to the cells. After 3 min incubation, the 
signal was preserved. No effect of trypsin on nonpermeabilized cells indicated that PINT 
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protein is localized internally. After removal of trypsin, digitonin was added (40 µM 
solution) and incubated for 3 min (Figure 24II B). Digitonin permeabilizes the plasma 
membrane and releases first cytosolic and later nuclear DsRed-Ex. Before this treatment the 
signal was bright, but after 3 min with digitonin it became weaker, showing that some of 
PINT-DsRed-Ex was localized freely in cytoplasm and nucleus. After digitonin was 
removed, trypsin was again added to the cells. 3 min later the signal was even weaker (Figure 
24II C), demonstrating that trypsin entered digitonin permeabilized cells and extinguished 
fluorescence from bound DsRed-Ex molecules facing the cytosol. The still remaining signal 
after trypsin treatment showed, that PINT-DsRed-Ex might be localized in mitochondria or 
ER (cartoon illustrating a possible cellular localization of PINT-DsRed-Ex is presented in 
Figure 24 I). After treatment with triton X-100 the signal totally vanished (Figure 24II D). 
Still, in some cases the red signal did not disappear, this was observer mostly in the cells that 
at the beginning gave very strong signal (Figure 24II E).    
 
 
I 
 
 
  II                               
       
A B C D E
Figure 24: FPP assay (using trypsin) of N2a cells transiently transfected with pDeRed-
Express-PINT: I. Cartoon of the FPP assay illustrating the cellular localization of PINT-
DsRed-Ex; II. A) Control cells washed with KHM buffer; B) the same cells after 3 min 
treatment with digitonin; C) cells after 3 min treatment with trypsin; D) cells after treatment 
with triton X-100; E) some other cells after triton X-100 treatment.   
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     Parallel experiment was performed with stable N2a-DsRed-Ex clones (Figure 25II A), and 
large differences between cells transfected with pDsRed-Express alone and pDsRed-Express-
PINT were observed. After 5 min treatment with digitonin almost all the signal had 
disappeared, only in the nucleus a weak signal remained (Figure 25II B), which disappeared 
30 seconds after trypsin addition to the cell. It seems that DsRed-Ex is bound to some 
structures in the nucleus of the cell. Cartoon showing cellular localization of Dsred-Ex is 
presented in Figure 25I.  
 
 
I 
 
II 
 
Figure 25: FPP assay (using trypsin) of sable N2a-DsRed-Ex cells: I. Cartoon of the FPP 
assay illustrating the cellular localization of DsRed-Ex; II. A) Control cells washed with 
KHM buffer; B) the same cells after 3 min treatment with digitonin; C) cells after 30 seconds 
treatment with trypsin.  
A B C
 
 
     Slightly different results were obtained when N2a cells transiently transfected with 
pDsRed-Express-PINT were treated with proteinase K instead of trypsin (Figure 26). 
Proteinase K is another serine protease that cleaves peptide bonds at the carboxylic sides of 
aliphatic, aromatic or hydrophobic amino acids. Transfected N2a cells were washed with 
KHM buffer (Figure 26 A) and incubated with digitonin at a final concentration of 40 µM for 
3 min (Figure 26 B). When digitonin was removed, proteinase K at a concentration of 50 
µg/ml was added. After 3 min incubation all signal had disappeared from some cells (Figure 
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26 C). Other cells were not affected by proteinase K and still gave a quite strong red signal, 
which did not vanish even after triton X-100 was added to the cells (Figure 26 D).  
 
 
 
Figure 26: FPP assay (using proteinase K) of N2a cells transiently transfected with pDsRed-
Express-PINT using proteinase K: A) control cells washed with KHM buffer; B) the same 
cells after 3 min treatment with digitonin; C) cells after 3 min treatment with proteinase K; D) 
other cells after proteinase K treatment. 
A B C D 
 
 
     To confirm the results of PINT protein localization from FPP assay, biochemical protease 
protection assay was also performed using trypsin and proteinase K (Figure 27). It seems, that 
DsRed-Ex is mostly localized freely in cytosol (lane b, band of 28 kDa) and some can be seen 
in membrane fraction after digitonin treatment (lane c). A band of 28 kDa is also seen in 
samples which were treated with trypsin and very weak band was seen after proteinase K 
treatment (lanes d and f, respectively). It might be that some of DsRed-Ex is protected from 
trypsin. Cells transiently transfected with pDsRed-Express-PINT gave a quite different 
picture. PINT-DsRed-Ex is seen in whole cell homogenate (Figure 27, lane A); some in 
cytosol just in oligomeric form (Figure 27, lane B, band heavier than 100 kDa) and a strong 
band at a size of 50 kDa was present in the membrane fraction after digitonin treatment 
(Figure 27, lane C). No difference was seen in lanes D and E (Figure 27) presenting samples 
added trypsin with and without triton X-100, respectively. As mentioned before, quite a few 
cells gave a fluorescent signal even after triton X-100 was added (Figure 24 E). It seems, that 
PINT-DsRed-Ex might form aggregates, and that proteinase K managed to penetrate those 
PINT-DsRed-Ex aggregates much better than trypsin (Figure 27, lane F), but still some signal 
remained even after triton X-100 addition (Figure 27, lane G).     
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Figure 27: Biochemical protease protection assay: N2a-DsRed-Ex cells: a) whole cell 
homogenate; b) cytosol fraction after digitonin treatment; c) membrane fraction after digitonin 
treatment; d) membrane fraction after trypsin; e) membrane fraction after trypsin and triton X-
100; f) membrane fraction after proteinase K; g) membrane fraction after proteinase K and 
triton X-100; N2a-PINT-DsRed-Ex cells: A) whole cell homogenate; B) cytosol fraction after 
digitonin treatment; C) membrane fraction after digitonin treatment; D) membrane fraction 
after trypsin; E) membrane fraction after trypsin and triton X-100; F) membrane fraction after 
proteinase K; G) membrane fraction after proteinase K and triton X-100; 12% polyacrylamide 
gel, signal detected with anti-RFP (1:16000) (Clontech) and goat-anti-rabbit HRP (1:15000).  
 
 
3.2 Stable transfection of SH-SY5Y cells 
 
     To achieve more physiological levels of PINT-DsRed-Ex protein expression in cells, and 
to avoid aggregate formation, stable transfection of SH-SY5Y cells was performed. In this 
kind of transfection cells that have inserted the foreign genetic material into their genome are 
selected. After applying selection pressure with G418 (drug for selection of stable mammalian 
cell lines) for some time, only the cells with a stable transfection remained. Stably transfected 
cells synthesize smaller amount of recombinant protein, making it easier to study cellular 
localization of PINT-DsRed-Ex protein (Figure 28).  
 
 
 
  
Figure 28: Stable transfected SH-SY-PINT-DsRed-Ex clones 
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     Western blot analysis was also performed to verify if PINT-DsRed-Ex was synthesized in 
stable clones (Figure 29). Lanes 3-6 confirmed that PINT was synthesized in stable clones, 
and that the amount of PINT protein is much smaller than in transiently transfected cells. 
Different stable clones gave somewhat different bands (lanes 3 and 5).  
 
 
 
1 2 3 4 5 6 
DsRed-Ex 
PINT-DsRed-Ex 
30 
40 
50 
KDa 
 
Figure 29: Western blot analysis of stable clones: 1- 2) untransfected SH-SY5Y cells with 
and without reducing agent, respectively; 3- 4) stable PINT-DsRed-Ex clone with and without 
reducing agent, respectively; 5- 6) another stable PINT-DsRed-Ex clone with and without 
reducing agent, respectively; 12% acrylamide gel, signal detected with anti-RFP (1:500) 
(Chemicon) and goat-anti-rabbit HRP (1:15000).  
 
 
     Stable clones were inspected in microscope. The clones in which cells looked mostly alike 
and gave even signal, and which gave relatively strong 50 kDa bands in western blots, were 
chosen for further studies of PINT protein.  
 
3.3 Glycosylation of PINT protein 
 
     To check if PINT is a glycoprotein, PINT-DsRed-Ex lysate from stable SH-SY-PINT-
DsRed-Ex clone was treated with PNGase F (Figure 30). No difference in bands sizes before 
and after treatment with PNGase F was observed, indicating that the PINT protein does not 
have attached carbohydrate residues attached and consequently is not a glycoprotein.  An 
additional unspecific very strong band around 35 kDa appeared after PNGase F treatment in 
all transfected and untransfected samples.  
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Figure 30: Treatment of stable SH-SY-PINT-DsRed-Ex clones with PNGase F: 1-2) 
untransfected SH-SY5Y cells before and after adding PNGase F, respectively; 3-4) stable SH-
SY-PINT-DsRed-Ex clone before and after PNGase F, respectively; 12% polyacrylamide gel, 
signal detected using anti-RFP (1:500) (Chemicon) and goat-anti-rabbit HRP (1:15000). 
 
 
3.4 Oligomerization of PINT-DsRed-Express 
 
     DsRed protein tends to form dimers, tetramers or even octamers at very high 
concentrations. This oligomerization can affect the behavior and localization of proteins that 
DsRed is fused to. Baird and colleagues (Baird et al., 2000) showed the multimeric nature of 
DsRed protein by various lines of evidence. One of the evidence was slow migration on SDS-
PAGE of DsRed protein unless sample was preboiled before application.  
     To analyze in what form PINT-DsRed-Ex is present in cells, the experiment published by 
Baird and colleagues was performed. Transiently transfected N2a cells were lysed with gentle 
IP-lysis buffer (se chapter 3.3 in Materials and Methods); lysates were added sample buffer 
with reducing agent, and analyzed in western blots (preboiled and not boiled before 
application). Results of this experiment are presented in Figure 31. Antibodies detected bands 
that were about 200 kDa and heavier in unboiled samples (Figure 31A, lanes 1 and 2), while 
band at about 50 kDa also appeared in boiled sample in addition to some heavy bands (Figure 
31 A, lane 3).  When DsRed-Ex fluorescence was scanned directly in the gel, the not boiled 
samples gave well defined and sharp bands at about 200 kDa, while no signal was seen in 
boiled sample (Figure 31B, lanes1-2 and 3, respectively).  It seems that PINT-DsRed-Ex in 
transiently transfected cells mostly forms oligomers.   
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Figure 31: Oligomerization of PINT-DsRed-Ex protein in transiently transfected N2a cells: 
A) Western blot using anti-RFP (1:16000) (Clontech) and goat-anti-rabbit HRP (1:15000); B) 
DsRed-Ex signal detected by direct fluorescence scanning of the gel with a variable mode 
imager (Typhoon 9200, Amersham Biosciences); 1-2) not boiled lysates, 3) boiled lysate; 
12% polyacrylamide gel.   
 
 
3.5 Leptomycin B experiment 
 
     Leptomycin B is a specific inhibitor of classical nuclear export, which is usually involving 
a leucine rich sequence. In the sequence of PINT protein quite a few leucines are presented. 
To check if PINT protein has an export signal, stable SH-SY-PINT clones were serum starved 
for 4 days before incubating with leptomycin B for 2.5 hours at 37 ºC in serum containing 
medium. Then the cells were fixed with formaldehyde and screened for fluorescence intensity 
(Figure 32). After leptomycin B treatment a slight difference between signal localization was 
observed, signal was seen in the nucleus as well as in cytoplasm (Figure 32B), while before 
treatment no signal was observed in the nucleus (Figure 32A).  It seems that PINT-DsRed-Ex 
might be localized in nucleus, but on the other hand, the difference is quite small and 
inconclusive, so it is difficult to conclude if PINT export is exportin dependent without further 
studies.  
 
 
   
Figure 32: Leptomycin B experiment, stable SH-SY-PINT-DsRed-Ex clones: A) control 
cells; B) cells added Leptomycin B. 
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3.6 PINT and PrP co-localization 
 
     To study the interaction between PINT and PrP protein N2a-PrP-EGFP cell line was used 
2a cells stably expressing prion protein tagged with GFP).  
green filters in the fluorescence 
      
ansfected with:  A-B) pDsRed-Express 
ilter; B,D) FITC filter, respectively.  
   Another way to check the interaction between proteins is by immunoprecipitation. 
 
e 
blot (1:100) were used as primary and secondary antibodies, respectively: 1) PrP-EGFP IP P4; 
2) PrP-EGFP-PINT IP P4; 3-4) PrP-EGFP and PrP-EGFP-PINT sates after IP with P4, 
(N
     PrP-EGFP cells were transiently transfected with DsRed-Ex alone or PINT-DsRed-Ex and 
pictures were taken 24 hours after transfection using red and 
microscope (Figure 33). When control cells (transfected with DsRed-Ex) (Figure 33A and B) 
were compared to cells tranfected with PINT (Figure 33C and D) a clear difference in the 
signal distribution was seen. However, it was difficult to decide if those proteins are localized 
in the same cell compartments because of overlapping excitation and emission wave lengths 
of EGFP and DsRed-Ex (Figure 9), which give a lot of false positive signal; red and green 
signals were seen together through FITC filter. 
 
 
A B C D 
Figure 33: Stable N2a-PrP-EGFP cells transiently tr
alone; or C-D) pDsRed-Express-PINT. A,C) TRITC f
 
 
  
  
 
Full leng
 
Figure 34: Western blot of immunoprecipitation, anti-PrP P4 (1:10000) and anti-mouse tru
ly
respectively; 5-6) PrP-EGFP and PrP-EGFP-PINT lysates before IP with P4, respectively; 7) 
PrP-EGFP IP anti-RFP; 8) PrP-EGFP-PINT IP anti-RFP; 9- 10) PrP-EGFP and PrP-EGFP-
PINT lysates after IP with anti-RFP, respectively; 11- 12) PrP-EGFP and PrP-EGFP-PINT 
lysates before IP with anti-RFP, respectively; 12% acrylamide gel.  
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     Figure 34 gave some positive evidence about interaction of PINT and PrP. Prion protein 
full length and N-terminal part) was immunoprecipitated with P4 ( from PrP-EGFP and PrP-
oprecipitation, anti-RFP (1:16000) (Clontech) and goat-
ry and secondary antibodies, respectively: 1) 
3-4) PrP-EGFP and PrP-EGFP-PINT lysates 
DsRed-Ex (50 kDa) was detected 
EGFP-PINT lysates (lanes 1 and 2) and with anti-RFP from PrP-EGFP-PINT lysate (lane 8). 
P4 antibody was more suitable for precipitation than anti-RFP. After precipitation with P4, 
almost no PrP was detected in lysates (lanes 3 and 4), while in PrP-EGFP-PINT lysate PrP 
signal was still quite strong (lane 10). Lane 7 also gave a weak signal of N-terminal part of 
PrP, but no full length PrP. It is possible that N-terminal part of PrP is so “sticky” that it 
bound A beads unspecificly and was detected. 
 
 
 
 
Figure 35: Western blot of immun
anti-rabbit HRP (1:15000) were used as prima
PrP-EGFP IP P4; 2) PrP-EGFP-PINT IP P4; 
1 2 3 4 5 6 7 8 9 10 11 40 
50 
60 
kDa 
after IP with P4, respectively; 5) PrP-EGFP-PINT lysate before IP with P4; 6) PrP-EGFP IP 
anti-RFP; 7) PrP-EGFP-PINT IP anti-RFP; 8- 9) PrP-EGFP and PrP-EGFP-PINT lysates after 
IP with anti-RFP, respectively; 10-11) PrP-EGFP and PrP-EGFP-PINT lysates before IP with 
anti-RFP, respectively; 12% polyacrylamide gel.  
 
     Figure 35 also showed some possible interaction between PINT and PrP. When P4 
ntibody was used for precipitation, a weak signal of PINT-a
only in the PrP-EGFP-PINT lysate (lane 2) but not in the PrP-EGFP lysate (lane 1). Anyhow, 
a strong signal of PINT-DsRed-Ex was seen in the lysate after precipitation (lane 5), showing 
that just a tiny fraction of protein had been precipitated. Immunoprecipitation with anti-RFP 
(lanes 6- 7) did not give any information about interaction, except for two heavy bands around 
120-220 kDa which also appeared in lane 2 IP with P4. There were no differences between 
lysates of PrP-EGFP and PrP-EGFP-PINT before and after immunoprecipitation with anti-
RFP (lanes 8-11, respectively).   
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IV. Discussion 
tein is of great interest, because of the possible interaction between 
INT and PrP , which functions still remains enigmatic. The main purpose of the present 
study was expression (in mammalian and bacterial cells) and characterization of PINT 
ssion of PINT protein in bacterial cells
 
     Studies of PINT pro
CP
protein.   
 
1. Expre  
     Expression of proteins in bacterial systems, especially in E.coli, plays a major role for the 
 their biological function does not 
odifications (Li et al., 2003). However, not every gene can be 
reported, which shows increased solubility of 
p
 
efficient production of genetically engineered proteins when
depend on posttranslational m
expressed efficiently in E.coli. This may be due to the unique and subtle structural features of 
the gene sequence encoding protein, the stability and translational efficiency of mRNA, the 
ease of protein folding, degradation of the protein by host cell proteases and potential toxicity 
of the protein to the host (reviewed by Makrides, 1996). The major drawbacks of E.coli as en 
expression system include the inability to perform many of the posttranslational modifications 
found in eukaryotic proteins, the lack for secretion mechanism for the efficient release of 
protein into the cultural medium, and the limited ability to facilitate extensive disulphide bond 
formation (reviewed by Makrides, 1996). All these downsides might lead to the formation of 
inactive aggregates of some proteins.    
     This study confirmed that His6-PINT protein is one of the proteins that forms insoluble 
aggregates when expressed in E.coli under optimal growth conditions (37 ºC) (Figure 19).  
     There are numerous single cases 
recombinant proteins at lower cultivation temperatures (reviewed by Hammarstrom et al., 
2002), but Hammarstrom and colleagues did not se the same effect on their set of proteins. No 
effect of lower growth tem eratures (16-30 ºC) was observed on the expression of His6-PINT 
protein in the present study either. It is reasonable to expect that larger proteins are more 
likely to have complex folding mechanisms, which render them more vulnerable to the 
aggregation associated with very high transcription rates at optimal growth temperatures. 
Lower growth temperature decreases formation of inclusion bodies, by making the growth 
cycle longer and giving more time for correct folding of large protein. Impaired solubility of 
smaller proteins (such as PINT protein) could, on the other hand, be an effect of less 
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temperature dependent factors such as missing cofactors, post-translational modifications, or 
folding partners. 
 
1.1 Advantage
 
s and disadvantages of inclusion bodies  
of proteins as inclusion bodies has certain advantages (reviewed by Li et al., 
oteins are often protected 
om proteolytic degradation by host cell enzymes; the inclusion body protein can easily be 
inants. Major 
asons for formation of inclusion bodies  
   Why some proteins tend to form inclusion bodies when expressed in E.coli, while others 
egate formation? To answer these 
uestions, several studies have been performed during the years. Specific support vector 
     Expression 
2003): the expression levels of protein are often very high; the pr
fr
separated from soluble proteins of the host cell by centrifugation, filtration or size-exclusion 
chromatography; if the expression product is toxic to the host, the formation of inactive 
protein can increase the viability of the cells and the yield of the target protein. Inclusion 
bodies often contain almost exclusively the over-expressed protein.  
     In the present study cells synthesized large amounts of His6-PINT protein (Figure 13). 
After cell lysis and several washes, SDS-PAGE analysis showed quite pure samples 
containing mostly His6-PINT protein (Figure 15), except for minor contam
contaminants of inclusion body material are most probably outer membrane proteins, which 
are themselves not part of the inclusion body particles but co-purify as non-solubilised protein 
with the inclusion body fraction. Separation of these membrane proteins from inclusion body 
material can be achieved by extensive washing with detergents (Lilie et al., 1998). 
     Disadvantages of aggregate formation are: highly problematic refolding of aggregated 
protein, refolded protein may not regain its biological activity, and reduction in final protein 
yield. 
  
1.2 Re
 
  
do not? What are the main factors that influence aggr
q
machine based algorithms for prediction of protein solubility were also recently created.  The 
composition and arrangement of amino acids in the protein seems to be a major influencing 
factor in deciding its aggregation propensity (Idicula-Thomas et al., 2006). The role of the 
primary structure was demonstrated by introduction of various point mutations into DNA 
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sequence coding for various proteins, and then observing their expression under identical 
conditions (Dale et al., 1994; Jenkins et al., 1995).  
     Wilkinson and colleagues observed that inclusion body formation is correlated to net 
charge, turn forming residue fraction, cysteine fraction, proline fraction, hydrophilicity and 
eterminant of solubility. A 
 some amino acids such as Glu, Arg, Gln, Ile, Leu, some dipeptides 
ary structure of the His6-PINT protein might also favour formation 
f insoluble inclusion bodies, the ProtParam program (Wilkins et al., 1999) on the ExPaSy 
on many factors, not only on primary structure of proteins.      
total number of residues (the first two parameters show the strongest correlation) (Wilkinson 
et al., 1991). Ser percentage composition is also shown to be an important factor in 
determining solubility of recombinant proteins (Goh et al., 2003).  
     Amongst the physicochemical properties considered, thermostability of proteins 
(represented by its aliphatic index) is found to be the most crucial d
higher instability index also increases the solubility of proteins. This observation suggests that 
a protein with a lower in vivo half-life has a lesser propensity to form inclusion bodies, 
because of shorter lived partially folded intermadiates of a protein (reviewed by Idicula- 
Thomas et al., 2006).  
     In summary, positive effect on solubility of recombinant protein have a high  aliphatic 
index, the presence of
(His-His, Arg-Ala, Gly-Ala and Arg-Gly), net charge (positive or negative), and the 
instability index of the entire protein and of its N-terminal. On the other hand, Gly, Cys, Met, 
Phe, Ser, Pro and Asn-Thr have negative effects (for amino acid letter code check Appendix 
5). 
 
     To find out if the prim
o
proteomics Server was used for calculation of different physicochemical properties. Results 
showed that the estimated half- life (time it takes for half of the amount of protein in a cell to 
disappear after its synthesis) of PINT is about 30 hours (mammalian reticulocytes in vitro), 
more than 20 hours (yeast in vivo) and more than 10 (E.coli in vivo). Instability index is 44.66 
(protein is unstable); aliphatic index is 84.36. Grand average of hydropathicity (sum of 
hydropathy values of all the amino acids, divided by the number of residues in the sequence) 
is -0.027. Proteins half-life and high aliphatic and instability indexes most probably decreases 
PINT inclusion body formation. On the other hand, the fraction of amino acids in PINT 
sequence that favours aggregation is higher than the fraction of amino acids that disfavours it.  
     It seems that primary structure of His6-PINT protein might favour formation of inclusion 
bodies, but it is not clear to what extent. Aggregation is a complicated process, which depends 
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     Sequence-independent factors such as the kinetics of translations (Cortazzo et al., 2005; 
Komar et al., 1999), absence of certain post-translational modifications and reducing 
environment of the cytoplasm (bacterial proteins contain few Cys residues and few disulphide 
express as inclusion bodies later has to be solubilised and refolded to facilitate 
m of in vivo protein folding remains one of the most 
triguing problems to be elucidated in molecular biology. There is no single refolding 
es also in 
bonds, so most proteins with stable disulphide bonds are exported from the cytoplasm. Thus, 
mammalian proteins which 3D structure depends in part on disulphide bond formation are not 
synthesized in the correct conformation in bacterial cytosol) (Makrides, 1996; Wilkinson et 
al., 1991) might also influence the solubility of proteins. A lot of aspect has to be considered 
in order to achieve expression of soluble His6-PINT protein.  
 
1.3 Refolding of PINT protein    
 
     Protein 
active and soluble protein. The mechanis
in
technique or method that satisfies all the refolding requirements of a protein. The proper 
chemical conditions also vary from protein to protein; several experiments are required in the 
search for the optimum refolding process. The efficiency of refolding depends on the 
equlibrium between correct folding and aggregation. To be successful in refolding one have to 
think about suitable protein concentration (not too high), conditions must be carefully 
optimized regarding external parameters, such as temperature, pH or ionic strength. 
     After all unsuccessful attempts to synthesize soluble PINT protein, a few different 
refolding methods have been performed in the present study. After several washes inclusion 
bodies were solubilised by a strong detergent. His6 tag retains its binding capabiliti
the presence of denaturing agents, so this tag was still used for purification of PINT with help 
of Ni-NTA columns. For solubilisation two strong detergents, guanidine hydrochloride and 
urea, were used. When solubilisation was performed at 4 ºC (with both detergents), all the 
protein was lost in the filter (Figure 16A) (the solution has to be filtered before loading onto 
the column, to avoid application of impurities), while protein solubilised at RT was pressed 
through the filter (Figure 16B). It was clear that RT is the most suitable temperature for 
solubilisation of PINT aggregates. Solubilised PINT protein containing a His6 tag was loaded 
onto the column and refolded by slowly washing away detergent. The elution of PINT was 
unsuccessful. The possible reasons might be very strong interaction between His and Ni ions, 
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precipitation of protein in the column caused by too high PINT concentration, or non-specific 
hydrophobic interactions.  
     The same negative results were obtained after dilution of solubilised PINT inclusion 
bodies (Figure 18). It is possible that protein was not bound to the column at all; or very 
.4 Increasing solubility; further studies 
dy has been problematic. All attempts to 
fold and obtain soluble and active PINT protein were negative. It seems that in this case 
ied. Hammarstrom and co-workers (Hammarstrom et al., 2001) observed large 
ns; introduction of amino acid substitutions might also be very 
strong interaction between His and Ni ions and non-specific hydrophobic interactions might 
be the problem; but most likely aggregation of PINT on the column was the main difficulty.   
 
1
 
     Refolding of PINT protein in the present stu
re
attempts to reduce the aggregation and misfolded configuration might be the better solution 
than solubilisation and refolding of protein. In further studies several factors could be 
changed: 
     Firstly, another expression system and the effect of several different fusion partners have 
to be stud
differences in the effects of fusion protein on the expression and solubility, but the 
combination of several fusion possibilities is still the key to the high overall success. His tag 
alone gives a lower chance of obtaining soluble product than with any other fusion, but can be 
kept for purification reasons.    
     The change of E.coli host strain or medium (Luan et al., 2004) might also increase 
solubility of recombinant protei
helpful. Moreover, co-expression of molecular chaperones (mediates posttranslational folding 
and localization of proteins) (Makrides, 1996), addition of low molecular weight molecules in 
refolding buffer (Zn2+, Ca2+ stabilise intermediates, low concentrations of urea (1- 2 M) and 
guanidine hydrochloride (0, 5- 1, 5 M) inhibit the intermolecular interactions that cause 
aggregation) (Li at al., 2003; Lilie et al., 1998), altered pH, sucrose and rafinose in growth 
medium might help to avoid incorrect folding of proteins.  
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2. Expression of PINT protein in the mammalian cells 
    
     To study expression, cellular localization and other characteristics of PINT protein, 
sRed-Express-PINT and 
Sv-PINT, coding for PINT-DsRed-Express and PINT-His  proteins, respectively.   
ith pDsRed-Express-PINT revealed 
 strictly cytosolic PINT-DsRed-Ex, others 
is was very different from cells transfected 
ent of DsRed-Ex to the C-terminus of a PINT protein, 
all molecules such as 
  
mammalian cells (N2a and SH-SY5Y were transfected with pD
pZeo 6
 
2.1 Cellular localization of PINT protein 
 
     Transient transfection of N2a and SH-SY5Y cells w
wo different localisation patterns. Some cells hadt
had PINT-DsRed-Ex in the nucleus (Figure 22). Th
with pDsRed-Express alone, which had a homogenous distribution of DsRed-Ex in the whole 
cell.  
     To do more thorough investigation of PINT-DsRed topology, a fluorescence protease 
protection assay (FPP) was used. FPP assay provides a new approach for determining protein 
topology in the cells. After the attachm
cells expressing the fusion protein were exposed to trypsin or proteinase K, either before or 
after plasma membrane permeabilisation by digitonin. If the fluorescent protein moiety faces 
the environment exposed to trypsin or proteinase K (that it, the cytoplasm), then its 
fluorescent signal should be lost. Conversely, if the fluorescent protein moiety faces the 
environment protected from trypsin (that is, lumen of a compartment) then its fluorescence 
should persist. Treatment of nonpermeabilized cells with trypsin or proteinase K should 
readily extinguish fluorescence associated with molecule facing the exterior of the cell, and 
have no effect on molecules facing the interior (Lorenz et al., 2006).  
     In the present study the intracellular signal remained after nonpermeabilized cells were 
treated with trypsin, showing that PINT is entirely localized internally.  After the addition of 
digitonin, cytosolic content of the cell diffuses out, and sm
trypsin/proteinase K can diffuse in to the cell. Notably, the permeabilizing effect of digitonin 
can be limited to the cholesterol-rich plasma membrane when used in the right concentration. 
Membranes of intracellular organelles have lower cholesterol concentration and are 
unaffected by digitonin concentrations permeabilizing the plasma membrane. Weaker 
fluorescent signal after digitonin treatment showed that some of PINT-DsRed-Ex was 
localized freely in cytoplasm (most probably as dimmers, showed by biochemical FPP assay 
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(Figure 27)). Addition of trypsin led to even fainter signal. It seems that some PINT-DsRed-
Ex was exposed to trypsin (bound and facing cytosol). Still remaining signal demonstrated 
that a small fraction of PINT-DsRed-Ex might be localized inside internal organelles 
(mitochondria or ER). Signal was entirely lost after addition of triton X-100, which 
permeabilize all membranes (Figure 24).  
     Interestingly, Lorenz and coworkers (Lorenz et al., 2006) also used proteinase K on their 
set of proteins, and obtained the same results, while in the present study some differences 
concerning PINT-DsRed-Ex were observed. The entire fluorescent PINT-DsRed-Ex signal 
 permeabilization, as expected, almost all the fluorescent 
ignal disappeared, except for minor signal in the nucleus, which fainted soon after trypsin 
 detected with anti-RFP 
dies in the membrane fraction, while cells in the microscope had lost all signal. Only 
was lost in chosen cells after addition of proteinase K (Figure 26). It seems that PINT-DsRed-
Ex might be somehow protected from trypsin (interestingly, PeptideCutter (one of ExPaSy 
tools) predicted that proteinase K might cut PINT protein into 111 peptides, while trypsin is 
only predicted to cut PINT in 22).  
 
     To check if FPP results are reliable the same experiment was performed on stable N2a-
DsRed-Ex cells (Figure 254). After
s
addition. DsRed-Ex in soluble form is localized freely in the cytoplasm and nucleus, and just 
minor fraction is bound to some structures in the nucleus of the cell. 
        
     Biochemical FPP assay and western blot analysis (Figure 27) showed interesting results. 
After trypsin and triton X-100 treatment, strong bands were still
antibo
the DsRed-Ex signal was preserved, while the gel stained with coomasie brilliant blue was 
almost clear, indicating that trypsin had digested all other proteins (results not shown).  After 
proteinase K and triton X-100 treatment, just a minor band was seen in the western blot, and 
no signal was seen in the microscope. This might be explained by a large amount of PINT 
protein synthesized during transient transfection that cells packed very tightly. Transiently 
transfected cells expressing PINT-DsRed-Ex were quite different. For microscope studies, 
only cells giving a nice and not too strong fluorescence signal were chosen, while some other 
transiently transfected cells synthesized so much PINT-DsRed-Ex protein, which gave very 
strong fluorescent signal. It seems that to deal with such large amounts of foreign protein, 
cells were trying to pack it very tightly. Those cells formed a lot of aggregates, which were 
protected from trypsin (Figure 24E) much better than from proteinase K (Figure 26D).   
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     Based on these results it can be concluded that PINT-DsRed is localized in cytoplasm (free 
and bound), and some might be localized in intracellular organelles such as mitochondria or 
.2 Import and export from nucleus (Leptomycin B experiment) 
 
x. A number 
f proteins travelling in and out of the cell nucleus have nuclear import (localizing) and export 
 by one or a 
1), which blocks 
binding of CRM1 to proteins containing the nuclear export signal. After treatment with 
ER. These results confirm theoretical predictions of some ExPaSy tools (CELLO, Subloc and 
others). From the PINT sequence it was predicted that PINT might be localized in the 
cytoplasm and/or might be exported to mitochondria. On the other hand, as mentioned above, 
in some transiently transfected cells PINT-DsRed-Ex signal was detected in the nucleus of the 
cells, while most of the stable SH-SY-PINT-DsRed-Ex clones showed both nuclear and 
cytosolic localisation in the same cells, most probably because of a lower amount of PINT-
DsRed-Ex in the cells. Maybe the cellular localization of PINT protein is cell cycle 
dependent, so that PINT enters the nucleus only at a certain point in the cycle, while 
otherwise being localized in the cytoplasm. Further studies are needed to examine this 
phenomenon, for instance by using synchronized cells and time-lapsed confocal microscopy 
to follow a complete cycle of cell division, or by using other methods that allow observation 
of cell cycle position and studies of the PINT-DsRed-Ex signal at the same time.   
 
2
     Transient transfections showed cells with and without nuclear PINT-DsRed-E
o
sequences. A nuclear localizing sequence (NLS) is an amino acid sequence which acts like a 
'tag' on the exposed surface of a protein. This sequence is used to confine the protein to the 
cell nucleus through the nuclear pore complex and to direct a newly synthesized protein into 
the nucleus via its recognition by cytosolic nuclear transport receptors. Typically, this signal 
consists of a few short sequences of positively charged lysines or arginines ((NH2)-Pro-Pro-
Lys-Lys-Lys-Arg-Lys-Val-(COOH)). PINT protein does not have typical NLS.  
     An NLS is the opposite of a nuclear export signal, which confines proteins to the cytosolic 
face of the nuclear membrane. Many export sequences contain leucins separated
few amino acids. In the PINT sequence, leucine constitutes more than 10% of the amino 
acids. Several streches of the primary sequence have repeated leucins separeted only by one 
amino acid, because of that the possibility of export signal was investigated.  
     Leptomycin B is a specific inhibitor of the nuclear export signal. The suggested inhibition 
mechanism involves the direct binding of Leptomycin B to CRM1 (exportin 
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leptomycin B, some differences were observed in fluorescent signal localization, but no 
convincing accumulation in the nucleus (Figure 32). Small particles (< 50 kDa) are able to 
pass through the nuclear pore complex by passive diffusion. PINT-DsRed-Ex seems to be on 
the limit between proteins that can and can not passively diffuse in and out of the nucleus. 
However, larger particles are also able to pass through the large diameter of the pore but at 
almost negligible rates. So it is also possible, that PINT-DsRed-Ex depend on passive 
diffusion, rather than on exportin 1 dependent export. However, many proteins known to 
switch between cytosol and nucleus are independent of exportin 1 (Kumar et al., 2006), so 
other transport proteins could be involved in PINT trafficking out of nucleus.   
 
2.3 Can PINT be an exonuclease? 
 
     It is difficult to answer question if PINT might have exonuclease activity, based only on 
there are two points that supports this suggestion. 
irstly, NCBI blast predicted that PINT protein has conservative Exonuc_X-T domain that is 
f DsRed as fluorescent tag 
    Wild type DsRed has many positive characteristics as tag-protein: bright fluorescence, 
the other hand, DsRed also proves to be at 
ast obligate tetramers, which may weakly associate into octamer (Baird et al., 2000; Gross et 
the results obtained from this study. But 
F
common to different exonucleases, ribonuclease T and different subunits of DNA polymerase. 
And secondly, based on the information from MisPred database, Exonuc_X-T domains were 
predicted as strongly multilocale, localized in nucleus and/or cytoplasm, and some in ER, as 
seen for the PINT protein. Further studies are needed for determining biological activity of 
PINT protein.   
 
2.4 The use o
 
 
stability against pH and photobleaching, but on 
le
al., 2000). Gross and colleagues reported that not boiled DsRed samples in SDS sample buffer 
gave heavy bands of 100 kDa and more in SDS-PAGE analysis, proving the obligate tetramer 
and/or possible octamer. The high molecular mass DsRed disappeared, however, when the 
sample was briefly boiled before electrophoresis. DsRed samples boiled before SDS-PAGE 
always showed two fragment bands of apparent masses 15 and 22 kDa; one band of about 35 
kDa was also formed.  It seems that DsRed samples undergo cleavage during boiling. In some 
western blots in this study a band around 20 kDa was also observed (Figure 23, 27) which 
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could indicate that some of the DsRed-Ex (mutant of wild type DsRed) was also cleaved by 
boiling.  
      
     DsRed-Express used in the present study contains 9 amino acid substitutions to increase 
the solubility of the protein, reduce time from transfection to detection of red fluorescence and 
ce the level or residual green emission. DsRed-Ex expressed alone was soluble and 
ddition of DsRed interferes with proper 
nctioning and localization of the fusion protein (Lauf et al., 2001), a matter that needs to be 
     In some cases, mostly when stable SH-SY-PINT-DsRed-Ex clones were analysed by 
ed multiple bands between 50 and 60 kDa. To 
heck if those bands were the result of glycosylation, lysates were treated with PNGase F. No 
No posttranslational modifications such as acetylation, O- and N- glycosylation, and oxidation 
redu
distributed throughout the entire cytoplasm and nucleus of expressing cells (Figure 22, 25), on 
the other hand, PINT-DsRed-Ex seems to tend to form oligomers (at least dimers and/or 
tetramers). PINT-DsRed-Ex aggregates first were observed in fluorescent microscope, and 
later confirmed by western blotting (Figure 31). The aggregates were packed so tightly that 
even boiling of the sample for 5 min could not destroy them; cells with aggregates were also 
not affected by trypsin and proteinase K treatment. 
 
     The question still remains to what extent fusion with this protein will affect location and 
functions of a protein of interest? In rare cases, a
fu
considered and addressed. Some other studies, however, have demonstrated that DsRed 
chimeras retain the characteristics of the untagged protein (Lee at al., 2002). To answer this 
question, PINT protein has to be fused to smaller tags, because large tags interfere with proper 
protein localization much more often than small tags. After expression in the same cell lines, 
the cellular localization of PINT has to be compared to localization of PINT-DsRed-Ex. If 
localizations match, DsRed-Ex does not affect PINT behaviour, but if they do not match, one 
of the tags influences PINT cellular localization and behaviour.   
 
2.5 Posttranslational modifications  
 
western blots, anti-RFP antibodies recogniz
c
difference between samples added and not added PNGase F was observed (Figure 30). This 
indicates that PINT is not a glycoprotein. 
     For prediction of other posttranslational modifications different ExPaCy tools were used. 
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were predicted for PINT protein except for possible phosphorylation of four Ser and four Thr 
residues and one N-myristoylation site. No disulphide bridges between protein molecules 
   The majority of PrP is imported into the ER lumen and attached to the luminal ER 
membrane and later the plasma membrane via a GPI anchor. Nevertheless, transmembrane 
us in the ER lumen and the other end facing the 
ytosol, and cytosolic forms of PrP have also been identified (reviewed by Griffoni at al., 
mbryonic development stages and in ovary, uterus, eye, lung, 
T-DsRed-Ex and PrP-EGFP was very widely in the cells making it 
ifficult to see if the two proteins were co-localized in some particular compartments. 
seem to be present in PINT-DsRed-Ex since no additional heavy bands appeared when no 
reducing agent was added before SDS-PAGE (Figure 23). This was as predicted, since PINT-
DsRed-Ex was shown to be localized in cytosol which is a reducing environment.  
 
 2.6 Interaction of PINT and PrP 
 
  
forms with either the N- or the C-termin
c
2003; Mironiv et al., 2003). Therefore, interaction of PrPC with PINT protein, which is mainly 
present in cytosol, is possible.  
     Spielhaupter and colleagues (Spielhaupter et al., 2001) reported the tissue distribution of 
murine PINT protein. A strong expression was detectable in brain as well as in heart, thyroid, 
and testis. A faint signal was visible in muscle cells, liver, pancreas, and kidney. No 
transcripts were detectable in e
and spleen. The tissue distribution of PrP mRNA has been published previously by Yehiely 
and colleagues (Yehiely et al., 1997). They reported a high expression of PrPC in brain, lung, 
kidney, and heart, and a weaker expression was seen in liver, spleen, and some other organs. 
The pattern of PINT expression partially overlaps with that of PrPC, indicating co-expression 
of proteins in these organs, and that these two proteins physically can interact with each other. 
Spielhaupter and colleagues identified murine PINT as possible PrP binding partner and 
demonstrated that the interaction is very strong. In the present study results about interaction 
were rather inconclusive.  
 
     Cells stably expressing PrP-EGFP were transfected with pDsRed-Express-PINT and 24 
hours after transfection images with fluorescent microscope were taken (Figure 33). However, 
the expression of both PIN
d
Another factor making it difficult to decide if those proteins are localized in the same cell 
compartments was the FITC filter on our microscope, which let much of the DsRed-Ex signal 
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through. Because of overlapping excitation and emission wave lengths of EGFP and DsRed-
Ex, red and green signals were seen together through the FITC filter; which then gave a lot of 
false positive signal. Perhaps confocal microscope with appropriate filter sets which let 
through narrow fixed wave length could give better resolution when studying co-localization 
of DsRed-Ex and EGFP-tagged proteins.  
 
     Co-immunoprecipitation of PrP-EGFP::PINT-DsRed-Ex complex with P4 (directed 
against PrP) and anti-RFP (directed against DsRed-Ex) was performed to study the interaction 
between the two proteins.  
     PrP (full length and N-terminal end) was detected after IP with P4 in lysates from 
 that P4 is an efficient IP-antibody. In contrast, after 
 
untransfected PrP-EGFP cells as well as from the same cells transfected with pDsRed-
Express-PINT (Figure 34). Little PrP was left in the lysate after immunoprecipitation with P4 
(lanes 3-4) which show
immunoprecipitation with anti-RFP strong PrP signal was still detected in cell lysate (lanes 9-
10), indicating that only a very little fraction of PrP was immunoprecipitated with anti-RFP. 
Weak PrP bands seen after immunoprecipitation with anti-RFP (lane 8) might show 
interaction between PrP and PINT, on the other hand, in untransfected cell lysate N-terminal 
end of PrP was also detected (lane 7). It is possible that N-terminal part of PrP is so “sticky” 
that it bound protein A beads unspecificly and was detected, or that weak bands of PrP 
immunoprecipitated with anti-RFP could indicate only unspecific binding of PrP to beads.  
     PINT protein was also detected in the same lysates (Figure 35). A lot of PINT was left in 
the lysates after immunoprecipitation with both P4 and anti-RFP (lanes 4 and 9, respectively), 
indicating that just a little fraction of PINT was immunoprecipitated and that these antibodies 
are inefficient IP-antibodies. A faint PINT signal was detected in transfected cell lysate after
IP with P4 (lane 2) and no signal in untransfected lysate (lane 1); this might indicates some 
kind of weak interaction between the proteins. Results from immunoprecipitation with anti-
RFP (lanes 6-7) are inconclusive when it comes to a study of protein interaction.       
     In order to prove the interaction between PrP and PINT, other antibodies, more suitable for 
IP and directed against PrP, EGFP, DsRed-Ex or PINT will have to be used, since the 
antibodies used in the present study are too inefficient.  
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2.7 anti-RFP antibody 
     In the present study two polyclonal anti-RFP antibodies from Chemicon and Clontech 
pitation and detection of PINT-DsRed-Ex signal. None of the 
FP-antibodies were suitable for immunoprecipitation of PINT-DsRed-Ex from cell lysates, 
 Clontech shows less unspecific binding, but still is not the 
     As mentioned before, DsRed-Ex could affect cellular localization and behaviour of PINT. 
T protein has to be studied under same conditions, in the 
e cell lines, but with other fusion partners. To eliminate the effect of DsRed-Ex on PINT 
te polypeptides, post-translational damage and culture growth 
 
were used for immunopreci
R
especially when the same antibody was used for both precipitation and detection of signal. It 
is possible that both these anti-RFP antibodies recognize several unspecific proteins in 
addition to DsRed-Ex. 
     Anti-RFP from Chemicon recognizes a protein in untransfected N2a and SH-SY5Y cells 
with the same size as PINT-DsRed-Ex (Figure 23), making in difficult to study PINT-DsRed-
Ex in the cells. The antibody from
optimal antibody for detection of DsRed-Ex.  
 
2.8 Expression of PINT-His6 
 
To check this fact, expression of PIN
sam
protein localization, six His residues were added to the C-terminal end of PINT and expressed 
in N2a cells. Two different anti-His tag antibodies were used for detection of signal in 
western blots, but all attempts were negative. One of the reasons can be that cells expressed 
too little protein and PINT was not detected, but PINT was not detected after upconcentration 
by immunoprecipitation with anti-His antibody either (both anti-His antibodies were checked 
with positive controls).  
     Some possible reasons why PINT-His6 was not detected or expressed in the cells might be: 
plasmid instability or plasmid loss; proteolytic degradation of the protein product caused by 
formation of incomple
parameters such as nutrient composition of media, growth temperature, and pH (Makrides, 
1996); different translation issues (Baneyx, 1996); and instability of mRNA (Makrides, 1996).  
     Further studies will be needed for expression of PINT with His6-tag. Expression conditions 
have to be carefully checked and optimized, or perhaps some other small tags can be used for 
successful expression of PINT protein in mammalian cells to double-check the cellular 
localization of this protein.     
 - 88 -
3. Future perspectives 
 
     Before this study not much was known about the PINT protein. Lorenz and colleagues 
ed that PINT is a possible PrP binding partner in mice. From the 
equence it was known that PINT probably has nuclease activity. 
ould consist of finding suitable 
inactive inclusion bodies. The protein has to be refolded and 
ein in western blots would become easier; it 
 immunoprecipitation and immunohistochemistry and to study 
me 
ize as PINT-DsRed-Ex. It would be useful to examine other anti-RFP antibodies, or perhaps 
Red-Express absorbs light at the 
e wave length as EGFP). Confocal microscope should be used, or perhaps another tag can 
(Lorenz et al., 2001) suggest
s
     In the present study, new information was gained about this protein, but still it is a very 
long way to go in order to characterize it properly. 
 
     First of all, in order to study the nuclease activity and other physicochemical properties, 
active and correctly folded protein is required. Further work w
conditions for solubilisation of 
the active product analyzed for nuclease activity and substrate specificity (DNA or RNA, 
single- or double-stranded and so on). 
 
     Secondly, specific antibodies can be made by injecting for instance rabbits with suitable 
amounts of PINT protein. Detection of PINT prot
would be possible to perform
localization without using fusion tags that may affect the behaviour of proteins.   
 
     Further work with co-transfection of PINT and PrP and co-localization is also needed. The 
anti-RFP antibody used in this study was not good because of unspecific bands at the sa
s
change fusion tags, to allow the use of other antibodies.  
 
     By using DsRed-Express and EGFP tags it is difficult to observe co-localization in the 
fluorescent microscope because of false positive signal (Ds
sam
be fused to the PINT protein.  
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Appendix 1 
Maps of different constructs used in this study. Restriction enzymes used for cutting vector 
re underlined in red. 
 
and PCR- product a
 
 
A. pDsRed-Express-PINT construct 
 
 
 
 
 
B. pZeoSv-PINT construct  
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C. pET- 16b vector 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. pET- PINT construct 
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Appendix 2 
ist of reagents and their manufacturers used in this study (in alphabetical order) 
Name of the reagent Manufacturer 
 
L
 
 
 
Reagents* 
Agarose Cambrex 
BSA Sigma 
CaCl2 Merck 
Chloroform Merck 
DacoCytomation fluorescent mounting med. Dako cytomation 
Digitonin Sigma 
DMSO Sigma 
dNTP Fermentas 
Ethidium bromide Quantum 
Glycerol Merck 
IPTG Saveen 
Lipofectamine Invitrogen 
Non Fat Dry Milk BioRad 
OPTI- MEM Invitrogen 
Phenol Applichem 
Plus reagents Invitrogen 
Protein A Sepharose Amersham Biosciences 
Protein G Agarose KLP 
Buffers** 
10x BamHI buffer Fermentas 
10x MOPS Running buffer BioRad 
10x NE Buffer 4 glad Biolabs New En
5x Phusion HF buffer es Finnzym
10x R buffer with BSA tas Fermen
2x Rapid ligation buffer Promega 
20 x XT MES Running buffer  BioRad
Enzymes 
AgeI (BshTI) Fermentas 
BamHI Promega 
BglII New England Biolabs 
Benzonase Sigma 
BSA HI New England Biolabs 
DNase I TaKaRa 
Lysozyme Sigma 
MluI Fermentas 
NdeI Fermentas 
Phusion DNA polymerase Finnzymes 
PNGase F New England Biolabs 
Protease inhibitor cocktail a Sigm
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Proteinase K Fluka, Biochemica 
T4 DNA ligase Promega 
Trypsin PAA Laboratories 
MW standards and dies 
6x Loading dye Fermentas 
6x Mass Ruler Loading Die  Fermentas
Bench Mark Invitrogen 
Fast ruler DNA ladder, high range entas Ferm
Fast ruler DNA ladder, low range Fermentas 
Fast ruler DNA ladder, middle range  Fermentas
Gene ruler 1 kb DNA ladder Fermentas 
Magic Mark en Invitrog
Mass Ruler DNA ladder mix, ready to use Fermentas 
NuPAGE LDS Sample buffer (4x)  Invitrogen
NuPAGE Sample Reducing agen en Invitrog
Page Ruler protein ladder Fermentas 
Precision Plus All Blue Protein Standards BioRad 
See Blue Invitrogen 
Trypan Blue solution (0, 4%) Sigma 
Antibiotics 
Ampicilin Duchefa Biochemie, Sigma 
Canamycin Sigma 
Chloramphenicol Duchefa Biochemie 
G- 418 tories PAA LAbora
Leptomycin B Sigma 
Zeocin Invitrogen 
Antibodies 
Anti-His(C-term) Amersham Bioscience, Invitrogen 
Anti- RFP  Chemicon, Clontech 
Goat anti- rabbit HRP BioRad 
Goat anti- mouse ALP Amersham Biosciences 
Goat anti- mouse HRP robes Molecular p
Mouse True Blot HRP eBioscience 
P4 R.Biopharm 
Kits 
E.Z.N.A Gel Extraction Kit - tek Omega Bio
Geneclean Spin Kit Q- Bio Gene 
Ni-NTA Spin Qiagen 
Pure Yield Plasmid Midiprep System a Promeg
Wizard Plus Sv Minipreps DNA Purification Promega 
System 
 
 
 
 
*- chemicals that were used for making of buffers are listed in Appendix 3 
**- buffers that were bought already mad its e, not from k
 
 
 - 101 -
Appendix 3 
 and media used in this  included in different 
ers marked with (*) - w  other colleagues.  
 
List of different buffers  study (buffers tha
ade by
t were
kits are not listed). Buff ere already m
 
 
1M Tris- HCl buffer 
ngus) 60. 55 g Tris base (A
 volumH2O to the end e of 500 ml 
the volum(Adjust pH with HCl before adjusting e) 
 
1x Sample buffer (for proteins) 
50 μl 4x2  XT Sample Buffer (BioRad) 
00 μl H2O 
0 μl DTT (20x Reducing agent) (BioRad) 
00 μl 1M MgCl2 (Sigma) 
6
5
1
 
1x TE- buffer 
0 ml 0, 1 M EDTA (Sigma, Bio Chemica) 1
1
H
0 ml 1M Tris- HCl 
2O to the end volume of 1 l; pH 8.0 
 
50 x TAE- buffer 
242 g Tris base (BioRad) 
0 ml H2O 
5. 71 ml acetic acid (Merck) 
10 ml 0, 5 M EDTA (Sigma) 
7
 
Benzonase buffer* 
20 mM Tris- HCl, pH 8.0 
2 mM MgCl2  
0. 02 % SDS 
. 02 % DTT 0
 
Destaining solution (for CBB staining) 
O 810 ml MQ H2
120 ml Methanol (Merck) 
70 ml Acetic acid (Merck) 
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Different solutions for silver staining 
l (Arcus)                                      
 ml Acetic acid (Merck)                                          
00 ml H2O 
olution B: 6g potassium tetrathionate (Merck) 
) 
l ethanol (Arcus) 
olution C: 2g AgNO3 (Merck) 
                 1000 ml H2O 
olution D*: 60 g potassium carbonate 
                 600 μl phormaldehyde 
                 250 μl 10% sodium thiosulphate pentadydrat 
                 H2O to the end volume of 2 l 
olution E: 80 g Tris base (Angus) 
                 40 ml Acetic acid (Merck) 
                 H2O to the end volume of 2 l 
Solution A: 600 ml ethano
                   200
                   12
                   
S
                   98 g calcium acetate (Merck
                   600 m
                   1400 ml H2O  
 
S
  
 
S
  
  
  
 
S
  
  
 
IP-lysis buffer 
100 mM Tris (Sigma) 
1% Triton- X 100 (Sigma) 
2 mM NaCl (Chemi Teknik) 
 8.0 Adjust pH to
 
IP-wash buffer 
50 mM Tris (Sigma) 
150 mM NaCl (Prolabo) 
0. 05% Triton- X 100 (Sigma) 
HM buffer*
Adjust pH to 7.4 
 
K  
B- medium
110 mM potassium acetate 
20 mM HEPES 
2 mM MgCl2 
 
L  
) (Duchefa Biochemie)  10/ 12. 5 g LB Broth (low/ high salt
H2O to and volume of 0. 5 l 
Adjust pH to 7.2 
 
N2a medium 
450 ml MEM (Sigma) 
5 ml FBS (Euroclone) 
5 ml puruvate and non- essential amino acids (Cambrex) 
, penicillin/ streptomycin (PAA Laboratories) 5 ml L- glutamine
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4. 33 ml Bicarbonate solution (Cambrex) 
r (solubilisation of inclusion bodies)NaCl-Tris buffe  
) 
) 
150 mM NaCl (Merck
50 mM Tris- HCl (pH 8.0
 
NZCYM- medium 
1. 29 g NZCYM BROTH EZ MIX (Sigma) 
ume of 1 l 
d antibiotic 
- T buffer
1
H2O to end vol
Autoclave for 20 min and ad
 
PBS* and PBS  
1. 5 g Di- sodium hydrogen orthophosphate, anhydrous 
 dihydrogen orthophosphate 
 (Adjust pH to 7.5) 
o PBS buffer add Tween 20 to give 0, 1% (v/ v) solution (USB) 
sion bodies)
1
2. 96 g sodium
5. 84 g NaCl 
H2O to the and volume of 1 l
To make PBS-T t
 
 
Phosphate buffer (inclu  
uffer (8x) (DE Healthcare) 20 mM Na phosphate b
0. 5 M NaCl (Merck) 
10 mM imidazole (pH 7.4) (GE Healthcare) 
 
Refolding buffer (inclusion bodies)  
10 mM Tris- HCl (pH 8.0) 
er) 
0 / 1 mM reduced/ oxidized glutathione (Sigma) 
cktail (1 ml to 100 ml of cell lysate) (Sigma) 
chloride (Fluka BioChemica) or urea 
IPA buffer*
100 mM Na2HPO4 (J.T.Bak
1
Protease inhibitor co
And suitable concentration of guanidine hydro
(Invitrogen) 
 
R  
H-SY5Y medium
150 mM NaCl 
1% NP- 40 
0. 5% DOC 
0. 1 SDS 
50 mM Tris (pH 7.5) 
 
S  
50 ml DMEM (Cambrex) 
mycin (PAA Laboratories) 
taining solution (for CBB)
4
5 ml FBS (Euroclone) 
5 ml L- glutamine (PAA Laboratories) 
5 ml penicillin/ strepto
 
S  
400 ml H2O 
500 ml Methanol (Merck) 
100 ml Acetic acid (Merck) 
1 g CBR- 250 (BioRad) 
Shake for 4 hours/ over night to dissolve the powder  
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Striping buffer* 
100 mM β- mercaptoethanol 
% (w/ v) SDS 
 HCl (pH 6.7) 
BS- T buffer
2
62. 5 mM Tris-
 
TBS* and T  
a- base 
 
e of 5 l; (Adjust pH to 7.6) 
o make TBS-T to TBS buffer add Tween 20 to give 0, 1% (v/ v) solution (USB) 
odies)
12. 1 g Trizm
40 g NaCl
H2O to the end volum
T
 
Washing buffer (inclusion b  
.0) 
0 / 1 mM reduced/ oxidized glutathione (Sigma) 
f urea (0- 6 M) (Invitrogen) 
20 mM Tris- HCl (pH 8
0. 5 NaCl (Merck) 
5 mM imidazole (GE Healthcare) 
1
And suitable concentration o
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Appendix 4 
) The distance tree of PINT (sheep) and a few homologous proteins (ovine PINT is marked 
 yellow); (B) colour code for homologous proteins from (A).   
A) 
(B) 
 
 
 
 
 
 
 
 
 
 
 
(A
in
 
(
 
Blast names color map 
     unknown 
     primates 
     mammals 
     rodents 
     birds 
     ciliates 
     bony fishes 
     echinoderms 
     kinetoplastids 
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Appendix 5 
ne and three letter sy r amino acids: 
One letter 
cod
Three letter code Full name 
 
O mbols fo
 
e 
A Ala Alanine 
B Asx Asparagine or aspartic acid 
C Cys Cysteine 
D Asp Aspartic acid 
E Glu Glutamic acid 
F Phe Plenylalanine 
G Gly Glycine 
H His Histidine 
I Ile Isoleucine 
K Lys Lysine 
L Leu Leucine 
M Met Methionine 
N Ans Asparagine 
P Pro Proline 
Q Gln Glutamine 
R Arg Arginine 
S Ser Serine 
T Thr Threonine 
V Val Valine 
W Trp Tryptophan 
Y Tyr Tyrosine 
Z Glx Glutam  acis ine or glutamic
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